<?xml version="1.0" encoding="iso-8859-1"?> 
<rss version="2.0" xmlns:creativeCommons="http://backend.userland.com/creativeCommonsRssModule" 
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" 
xmlns:atom="http://www.w3.org/2005/Atom"
>
<channel>
<title>International Journal of Biological Sciences</title> 
<link>http://www.biolsci.org</link> 
<description>International Journal of Biological Sciences RSS feed -- Volume 8</description> 
<language>en-us</language> 
<pubDate>Fri, 20 Apr 2012 04:00:00 GMT</pubDate>
<lastBuildDate>Fri, 20 Apr 2012 04:00:00 GMT</lastBuildDate> 

<item>
<link>http://www.biolsci.org/v08p0596.htm</link> 
<title>The Gain of Function of p53 Mutant p53S in Promoting Tumorigenesis by Cross-talking with H-RasV12</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0596.htm</guid> 
<description><![CDATA[ <p>The loss of wild type p53 tumor suppressive function and oncogenic gain-of-function of p53 mutants have been showing important implications in tumorigenesis. The p53<sup>N236S</sup> (p53<sup>N239S</sup> in human, p53S) mutation has been shown to lose wild type p53 function by yeast assay. However, its gain of function is still not clear. By gel shift assay, we showed that mutant p53S had lost its DNA binding ability to its target promoters. Further real-time PCR data confirmed that p53S had lost the function of regulating the transcription of p21<sup> Cip1/Waf1</sup>, cyclin G, PUMA, and Bax in response to 10Gy irradiation. These data confirmed the loss of function of p53S in mammalian cells. By xenograft assay, we showed that the p53S <i>per se</i> was not oncogenic enough to form tumor, however, cooperating with H-RasV12, p53S could dramatically promote tumorigenesis in p53 null MEFs. Further study showed that co-expression of p53S and H-RasV12 could increase the expression level of H-RasV12 and partially eliminate the elevation of stress response proteins such as Chk2, &#947;-H2AX, Hsp70, Rb, p16<sup>Ink4a</sup> caused by either p53S or H-RasV12. These data suggested that p53S cross-talked with H-RasV12 and reduced the cellular stress response to oncogenic signals, which facilitated the cell growth and tumorigenesis. Together these data provided the molecular basis for the cooperation of p53S and H-RasV12 and revealed the gain of function of p53S in cross-talking with H-RasV12. This study revealed an important aspect of gain of function for p53 mutant, therefore might shed light on the clinical strategy in targeting p53 mutant.</p> ]]></description>  
<dc:creator>Shuting Jia, Lanjun Zhao, Wenru Tang, Ying Luo</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>5</prism:number> 
  <prism:startingPage>596</prism:startingPage> 
  <prism:endingPage>605</prism:endingPage> 
  <prism:publicationDate>2012-4-18</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0580.htm</link> 
<title>Genome-Wide Association Analysis of Meat Quality Traits in a Porcine Large White &#215; Minzhu Intercross Population</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0580.htm</guid> 
<description><![CDATA[ <p>Pork quality is an economically important trait and one of the main selection criteria for breeding in the swine industry. In this genome-wide association study (GWAS), 455 pigs from a porcine Large White &#215; Minzhu intercross population were genotyped using the Illumina PorcineSNP60K Beadchip, and phenotyped for intramuscular fat content (IMF), marbling, moisture, color L*, color a*, color b* and color score in the longissimus muscle (LM). Association tests between each trait and the SNPs were performed via the Genome Wide Rapid Association using the Mixed Model and Regression-Genomic Control (GRAMMAR-GC) approach. From the Ensembl porcine database, SNP annotation was implemented using <i>Sus scrofa</i> Build 9. A total of 45 SNPs showed significant association with one or multiple meat quality traits. Of the 45 SNPs, 36 were located on SSC12. These significantly associated SNPs aligned to or were in close approximation to previously reported quantitative trait loci (QTL) and some were located within introns of previously reported candidate genes. Two haplotype blocks ASGA0100525-ASGA0055225-ALGA0067099-MARC0004712-DIAS0000861, and ASGA0085522-H3GA0056170 were detected in the significant region. The first block contained the genes <i>MYH1</i>, <i>MYH2</i> and <i>MYH4</i>. A SNP (ASGA0094812) within an intron of the <i>USP43</i> gene was significantly associated with five meat quality traits. The present results effectively narrowed down the associated regions compared to previous QTL studies and revealed haplotypes and candidate genes on SSC12 for meat quality traits in pigs.</p> ]]></description>  
<dc:creator>Weizhen Luo, Duxue Cheng, Shaokang Chen, Ligang Wang, Yong Li, Xiaojun Ma, Xin Song, Xin Liu, Wen Li, Jing Liang, Hua Yan, Kebin Zhao, Chuduan Wang, Lixian Wang, Longchao Zhang</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>4</prism:number> 
  <prism:startingPage>580</prism:startingPage> 
  <prism:endingPage>595</prism:endingPage> 
  <prism:publicationDate>2012-4-18</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0561.htm</link> 
<title>Characterization of the Complete Mitochondrial Genomes of Cnaphalocrocis medinalis and Chilo suppressalis (Lepidoptera: Pyralidae)</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0561.htm</guid> 
<description><![CDATA[ <p>The complete mitochondrial genomes (mitogenomes) of <i>Cnaphalocrocis medinalis </i>and <i>Chilo suppressalis </i>(Lepidoptera: Pyralidae) were determined and analyzed. The circular genomes were 15,388 bp long for <i>C. medinalis </i>and 15,395 bp long for <i>C. suppressalis</i>. Both mitogenomes contained 37 genes, with gene order similar to that of other lepidopterans. Notably, 12 protein-coding genes (PCGs) utilized the standard ATN, but the <i>cox1</i> gene used CGA as the initiation codon; the <i>cox1</i>, <i>cox2</i>, and <i>nad4</i> genes in the two mitogenomes had the truncated termination codons T, T, and TA, respectively, but the <i>nad5</i> gene was found to use T as the termination codon only in the <i>C</i>.<i> medinalis </i>mitogenome. Additionally, the codon distribution and Relative Synonymous Codon Usage of the 13 PCGs in the <i>C</i>.<i> medinalis </i>mitogenome were very different from those in other pyralid moth mitogenomes. Most of the tRNA genes had typical cloverleaf secondary structures. However, the dihydrouridine (DHU) arm of the <i>trnS1(AGN)</i> gene did not form a stable stem-loop structure. Forty-nine helices in six domains, and 33 helices in three domains were present in the secondary structures of the <i>rrnL</i> and <i>rrnS</i> genes of the two mitogenomes, respectively. There were four major intergenic spacers, except for the A+T-rich region, spanning at least 12 bp in the two mitogenomes. The A+T-rich region contained an 'ATAGT(A)'-like motif followed by a poly-T stretch in the two mitogenomes. In addition, there were a potential stem-loop structure, a duplicated 25-bp repeat element, and a microsatellite '(TA)<sub>13</sub>' observed in the A+T-rich region of the <i>C</i>.<i> medinalis </i>mitogenome. A poly-T motif, a duplicated 31-bp repeat element, and a 19-bp triplication were found in the <i>C</i>.<i> suppressalis </i>mitogenome. However, there are many differences in the A+T-rich regions between the <i>C</i>.<i> suppressalis </i>mitogenome sequence in the present study and previous reports. Finally, the phylogenetic relationships of these insects were reconstructed based on amino acid sequences of mitochondrial 13 PCGs using Bayesian inference and maximum likelihood methods. These molecular-based phylogenies support the traditional morphologically based view of relationships within the Pyralidae.</p> ]]></description>  
<dc:creator>Huan-Na Chai, Yu-Zhou Du, Bao-Ping Zhai</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>4</prism:number> 
  <prism:startingPage>561</prism:startingPage> 
  <prism:endingPage>579</prism:endingPage> 
  <prism:publicationDate>2012-4-17</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0548.htm</link> 
<title>Data Mining in Networks of Differentially Expressed Genes during Sow Pregnancy</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0548.htm</guid> 
<description><![CDATA[ <p>Small to moderate gains in Pig fertility can mean large returns in overall efficiency, and developing methods to improve it is highly desirable. High fertility rates depend on completion of successful pregnancies. To understand the molecular signals associated with pregnancy in sows, expression profiling experiments were conducted to identify differentially expressed genes in ovary and myometrium at different pregnancy periods using the Affymetrix Porcine GeneChip<sup>TM</sup>. A total of 974, 1800, 335 and 710 differentially expressed transcripts were identified in the myometrium during early pregnancy (EP) and late pregnancy (LP), and in the ovary during EP and LP, respectively. Self-Organizing Map (SOM) clusters indicated the differentially expressed genes belonged to 7 different functional groups. Based on BLASTX searches and Gene Ontology (GO) classifications, 129 unique genes closely related to pregnancy showed differential expression patterns. GO analysis also indicated that there were 21 different molecular function categories, 20 different biological process categories, and 8 different cellular component categories of genes differentially expressed during sow pregnancy. Gene regulatory network reconstruction provided us with an interaction model of known genes such as insulin-like growth factor 2 (<i>IGF2</i>) gene, estrogen receptor (<i>ESR</i>) gene, retinol-binding protein-4 (<i>RBP4</i>) gene, and several unknown candidate genes related to reproduction. Several pitch point genes were selected for association study with reproduction traits. For instance, <i>DPPA5</i> g.363 T&#62;C was found to associate with litter born weight at later parities in Beijing Black pigs significantly (<i>p</i> &#60; 0.05). Overall, this study contributes to elucidating the mechanism underlying pregnancy processes, which maybe provide valuable information for pig reproduction improvement.</p> ]]></description>  
<dc:creator>Ligang Wang, Longchao Zhang, Yong Li, Wen Li, Weizhen Luo, Duxue Cheng, Hua Yan, Xiaojun Ma, Xin Liu, Xin Song, Jing Liang, Kebin Zhao, Lixian Wang</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>4</prism:number> 
  <prism:startingPage>548</prism:startingPage> 
  <prism:endingPage>560</prism:endingPage> 
  <prism:publicationDate>2012-4-16</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0533.htm</link> 
<title>Isoalantolactone Induces Reactive Oxygen Species Mediated Apoptosis in Pancreatic Carcinoma PANC-1 Cells</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0533.htm</guid> 
<description><![CDATA[ <p>Isoalantolactone, a sesquiterpene lactone compound possesses antifungal, antibacteria, antihelminthic and antiproliferative activities. In the present study, we found that isoalantolactone inhibits growth and induces apoptosis in pancreatic cancer cells. Further mechanistic studies revealed that induction of apoptosis is associated with increased generation of reactive oxygen species, cardiolipin oxidation, reduced mitochondrial membrane potential, release of cytochrome c and cell cycle arrest at S phase. N-Acetyl Cysteine (NAC), a specific ROS inhibitor restored cell viability and completely blocked isoalantolactone-mediated apoptosis in PANC-1 cells indicating that ROS are involved in isoalantolactone-mediated apoptosis. Western blot study showed that isoalantolactone increased the expression of phosphorylated p38 MAPK, Bax, and cleaved caspase-3 and decreased the expression of Bcl-2 in a dose-dependent manner. No change in expression of phosphorylated p38 MAPK and Bax was found when cells were treated with isoalantolactone in the presence of NAC, indicating that activation of these proteins is directly dependent on ROS generation. The present study provides evidence for the first time that isoalantolactone induces ROS-dependent apoptosis through intrinsic pathway. Furthermore, our in vivo toxicity study demonstrated that isoalantolactone did not induce any acute or chronic toxicity in liver and kidneys of CD1 mice at dose of 100 mg/kg body weight. Therefore, isoalantolactone may be a safe chemotherapeutic candidate for the treatment of human pancreatic carcinoma.</p> ]]></description>  
<dc:creator>Muhammad Khan, Chuan Ding, Azhar Rasul, Fei Yi, Ting Li, Hongwen Gao, Rong Gao, Lili Zhong, Kun Zhang, Xuedong Fang, Tonghui Ma</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>4</prism:number> 
  <prism:startingPage>533</prism:startingPage> 
  <prism:endingPage>547</prism:endingPage> 
  <prism:publicationDate>2012-3-28</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0522.htm</link> 
<title>TWIST Represses Estrogen Receptor-alpha Expression by Recruiting the NuRD Protein Complex in Breast Cancer Cells</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0522.htm</guid> 
<description><![CDATA[ <p>Loss of estrogen receptor &#945; (ER&#945;) expression and gain of TWIST (TWIST1) expression in breast tumors correlate with increased disease recurrence and metastasis and poor disease-free survival. However, the molecular and functional regulatory relationship between TWIST and ER&#945; are unclear. In this study, we found TWIST was associated with a chromatin region in intron 7 of the human <i>ESR1</i> gene coding for ER&#945;. This association of TWIST efficiently recruited the nucleosome remodeling and deacetylase (NuRD) repressor complex to this region, which subsequently decreased histone H3K9 acetylation, increased histone H3K9 methylation and repressed <i>ESR1</i> expression in breast cancer cells. In agreement with these molecular events, TWIST expression was inversely correlated with ER&#945; expression in both breast cancer cell lines and human breast ductal carcinomas. Forced expression of TWIST in TWIST-negative and ER&#945;-positive breast cancer cells such as T47D and MCF-7 cells reduced ER&#945; expression, while knockdown of TWIST in TWIST-positive and ER&#945;-negative breast cancer cells such as MDA-MB-435 and 4T1 cells increased ER&#945; expression. Furthermore, inhibition of histone deacetylase (HDAC) activity including the one in NuRD complex significantly increased ER&#945; expression in MDA-MB-435 and 4T1 cells. HDAC inhibition together with TWIST knockdown did not further increase ER&#945; expression in 4T1 and MDA-MB-435 cells. These results demonstrate that TWIST/NuRD represses ER&#945; expression in breast cancer cells. Therefore, TWIST may serve as a potential molecular target for converting ER&#945;-negative breast cancers to ER&#945;-positive breast cancers, allowing these cancers to restore their sensitivity to endocrine therapy with selective ER&#945; antagonists such as tamoxifen and raloxifene.</p> ]]></description>  
<dc:creator>Junjiang Fu, Lianmei Zhang, Tao He, Xiuli Xiao, Xiaoyan Liu, Li Wang, Luquan Yang, Manman Yang, Tiandan Zhang, Rui Chen, Jianming Xu</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>4</prism:number> 
  <prism:startingPage>522</prism:startingPage> 
  <prism:endingPage>532</prism:endingPage> 
  <prism:publicationDate>2012-3-22</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0512.htm</link> 
<title>Propolis Standardized Extract (EPP-AF&#174;), an Innovative Chemically and Biologically Reproducible Pharmaceutical Compound for Treating Wounds</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0512.htm</guid> 
<description><![CDATA[ <p>The aim of this study was to develop a formulation, containing the propolis standardized extract (EPP-AF<sup>&#174;</sup>), which can assist in the healing of skin lesions. To achieve this objective the antimicrobial activity and chemical composition of the propolis extract was determined. The final product was subjected to <i>in vitro</i> and <i>in vivo</i> pre-clinical evaluation. The broth macrodilution method was used to determine the antimicrobial activity of the extracts and formulations against the microorganisms most commonly found in burns, <i>Pseudomonas aeruginosa</i>, <i>Klebsiella pneumoniae</i>, <i>Escherichia coli</i>, <i>Staphylococcus aureus</i> and <i>Staphylococcus epidermidis</i>. <i>Wistar</i> rats with puncture wounded skin were used to evaluate the wound healing properties of propolis. The results of chemical and biological characterization demonstrated the batch-to-batch reproducibility of the standardized extract which is an unprecedented result. The antimicrobial and wound healing activity of the pharmaceutical studied showed the best results when samples contain 3.6% propolis, suggesting that this is the most promising composition.</p> ]]></description>  
<dc:creator>Andresa Aparecida Berretta, Andresa Piacezzi Nascimento, Paula Carolina Pires Bueno, Mirela Mara de Oliveira Lima Leite Vaz, Juliana Maldonado Marchetti</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>4</prism:number> 
  <prism:startingPage>512</prism:startingPage> 
  <prism:endingPage>521</prism:endingPage> 
  <prism:publicationDate>2012-3-21</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0498.htm</link> 
<title>Characterization of Bovine Induced Pluripotent Stem Cells by Lentiviral Transduction of Reprogramming Factor Fusion Proteins</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0498.htm</guid> 
<description><![CDATA[ <p>Pluripotent stem cells from domesticated animals have potential applications in transgenic breeding. Here, we describe induced pluripotent stem (iPS) cells derived from bovine fetal fibroblasts by lentiviral transduction of Oct4, Sox2, Klf4 and c-Myc defined-factor fusion proteins. Bovine iPS cells showed typical colony morphology, normal karyotypes, stained positively for alkaline phosphatase (AP) and expressed Oct4, Nanog and SSEA1. The CpG in the promoter regions of <i>Oct4</i> and <i>Nanog</i> were highly unmethylated in bovine iPS cells compared to the fibroblasts. The cells were able to differentiate into cell types of all three germ layers <i>in vitro</i> and <i>in vivo</i>. In addition, these cells were induced into female germ cells under defined culture conditions and expressed early and late female germ cell-specific genes <i>Vasa</i>, <i>Dazl</i>, <i>Gdf9</i>, <i>Nobox</i>, <i>Zp2</i>, and <i>Zp3</i>. Our data suggest that bovine iPS cells were generated from bovine fetal fibroblasts with defined-factor fusion proteins mediated by lentivirus and have potential applications in bovine transgenic breeding and gene-modified animals.</p> ]]></description>  
<dc:creator>Hongguo Cao, Pan Yang, Yong Pu, Xueping Sun, Huiqun Yin, Yu Zhang, Yunhai Zhang, Yunsheng Li, Ya Liu, Fugui Fang, Zijun Zhang, Yong Tao, Xiaorong Zhang</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>4</prism:number> 
  <prism:startingPage>498</prism:startingPage> 
  <prism:endingPage>511</prism:endingPage> 
  <prism:publicationDate>2012-3-21</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0486.htm</link> 
<title>A Comparative Study of Mammalian Diversification Pattern</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0486.htm</guid> 
<description><![CDATA[ <p>Although mammals have long been regarded as a successful radiation, the diversification pattern among the clades is still poorly known. Higher-level phylogenies are conflicting and comprehensive comparative analyses are still lacking. Using a recently published supermatrix encompassing nearly all extant mammalian families and a novel comparative likelihood approach (MEDUSA), the diversification pattern of mammalian groups was examined. Both order- and family-level phylogenetic analyses revealed the rapid radiation of Boreoeutheria and Euaustralidelphia in the early mammalian history. The observation of a diversification burst within Boreoeutheria at approximately 100 My supports the Long Fuse model in elucidating placental diversification progress, and the rapid radiation of Euaustralidelphia suggests an important role of biogeographic dispersal events in triggering early Australian marsupial rapid radiation. Diversification analyses based on family-level diversity tree revealed seven additional clades with exceptional diversification rate shifts, six of which represent accelerations in net diversification rate as compared to the background pattern. The shifts gave origin to the clades Muridae+Cricetidae, Bovidae+Moschidae+Cervidae, Simiiformes, Echimyidae, Odontoceti (excluding Physeteridae+Kogiidae+Platanistidae), Macropodidae, and Vespertilionidae. Moderate to high extinction rates from background and boreoeutherian diversification patterns indicate the important role of turnovers in shaping the heterogeneous taxonomic richness observed among extant mammalian groups. Furthermore, the present results emphasize the key role of extinction on erasing unusual diversification signals, and suggest that further studies are needed to clarify the historical radiation of some mammalian groups for which MEDUSA did not detect exceptional diversification rates.</p> ]]></description>  
<dc:creator>Wenhua Yu, Junxiao Xu, Yi Wu, Guang Yang</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>4</prism:number> 
  <prism:startingPage>486</prism:startingPage> 
  <prism:endingPage>497</prism:endingPage> 
  <prism:publicationDate>2012-3-14</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0470.htm</link> 
<title>The Function of Steroid Receptor Coactivator-1 in Normal Tissues and Cancer</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0470.htm</guid> 
<description><![CDATA[ <p>In 1995, the steroid receptor coactivator-1 (SRC-1) was identified as the first authentic steroid receptor coactivator. Since then, the SRC proteins have remained at the epicenter of coregulator biology, molecular endocrinology and endocrine-related cancer. Cumulative works on SRC-1 have shown that it is primarily a nuclear receptor coregulator and functions to construct highly specific enzymatic protein complexes which can execute efficient and successful transcriptional activation of designated target genes. The versatile nature of SRC-1 enables it to respond to steroid dependent and steroid independent stimulation, allowing it to bind across many families of transcription factors to orchestrate and regulate complex physiological reactions. This review highlights the multiple functions of SRC-1 in the development and maintenance of normal tissue functions as well as its major role in mediating hormone receptor responsiveness. Insights from genetically manipulated mouse models and clinical data suggest SRC-1 is significantly overexpressed in many cancers, in particular, cancers of the reproductive tissues. SRC-1 has been associated with cellular proliferation and tumor growth but its major tumorigenic contributions are promotion and execution of breast cancer metastasis and mediation of resistance to endocrine therapies. The ability of SRC-1 to coordinate multiple signaling pathways makes it an important player in tumor cells' escape of targeted therapy.</p> ]]></description>  
<dc:creator>Claire A. Walsh, Li Qin, Jean Ching-Yi Tien, Leonie S. Young, Jianming Xu</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>4</prism:number> 
  <prism:startingPage>470</prism:startingPage> 
  <prism:endingPage>485</prism:endingPage> 
  <prism:publicationDate>2012-3-7</prism:publicationDate> 
<prism:section>Review</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0459.htm</link> 
<title>OLFML3 Expression is Decreased during Prenatal Muscle Development and Regulated by MicroRNA-155 in Pigs</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0459.htm</guid> 
<description><![CDATA[ <p>The Olfactomedin-like 3 (<i>OLFML3)</i> gene has matrix-related function involved in embryonic development. MicroRNA-155 (miR-155), 21- to 23-nucleotides (nt) noncoding RNA, regulated myogenesis by target mRNA. Our LongSAGE analysis suggested that <i>OLFML</i>3 gene was differently expressed during muscle development in pig<i>.</i> In this study, we cloned the porcine <i>OLFML3</i> gene and detected its tissues distribution in adult Tongcheng pigs and dynamical expression in developmental skeletal muscle (12 prenatal and 10 postnatal stages) from Landrace (lean-type) and Tongcheng (obese-type) pigs. Subsequently, we analyzed the interaction between <i>OLFML3</i> and miR-155. The <i>OLFML3</i> was abundantly expressed in liver and pancreas, moderately in lung, small intestine and placenta, and weakly in other tissues and postnatal muscle. There were different dynamical expression patterns between Landrace and Tongcheng pigs during prenatal skeletal muscle development. The <i>OLFML3</i> was down-regulated (33-50 days post coitus, dpc), subsequently up-regulated (50-70 dpc), and then down-regulated (70-100 dpc) in Landrace pigs, while in Tongcheng pigs, it was down-regulated (33-50 dpc), subsequently up-regulated (50-55 dpc) and then down-regulated (55-100 dpc). There was higher expression in Tongcheng than Landrace in prenatal muscle from 33 to 60 dpc, and opposite situation from 65 to 100 dpc. Dual luciferase assay and real time PCR documented that <i>OLFML3</i> expression was regulated by miR-155 at mRNA level. Our research indicated that <i>OLFML3</i> gene may affect prenatal skeletal muscle development and was regulated by miR-155. These finding will help understanding biological function and expression regulation of <i>OLFML3</i> gene in mammal animals.</p> ]]></description>  
<dc:creator>Shuanping Zhao, Jing Zhang, Xinhua Hou, Linsen Zan, Ning Wang, Zhonglin Tang, Kui Li</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>4</prism:number> 
  <prism:startingPage>459</prism:startingPage> 
  <prism:endingPage>469</prism:endingPage> 
  <prism:publicationDate>2012-3-3</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0451.htm</link> 
<title>The Silencing of RECK Gene is Associated with Promoter Hypermethylation and Poor Survival in Hepatocellular Carcinoma</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0451.htm</guid> 
<description><![CDATA[ <p><b>Background: </b>To evaluate the promoter methylation status of RECK gene and mRNA expression in patients with hepatocellular carcinoma (HCC).</p><p><b>Methods:</b> We analyzed RECK methylation by MSP, and RECK mRNA by real-time PCR in 74 HCC. The liver cell lines (7721, Chang and Hep-G2) were treated with 5-Aza-CdR and TSA.</p><p><b>Results: </b>RECK mRNA were lower in HCC tissues (Mean <sub>-&#8710;Ct</sub> = -3.29) than that in Non-Hcc tissues (Mean <sub>-&#8710;Ct</sub> = -2.42). Expression of RECK was elevated in only 24 (32.43%) of the 74 HCC patients but decreased (-&#8710;&#8710;Ct&#60;0) in 50 (67.57%) of the patients. RECK promoter was hypermethylated in 55.4% (41/74) of HCCs, and in only 17.6% (13/74) of Non-Hcc samples. RECK mRNA were lower in HCC patients with hypermethylation (&#8710;MI&#62;=0.5) (Mean <sub>-&#8710;&#8710;Ct</sub> = -1.75) than those with demethylation (&#8710;MI&#60;0.5) (Mean <sub>-&#8710;&#8710;Ct</sub> = 0.05), and there is a decreased tendency for RECK mRNA in HCC patients with promoter hypermethylation (<i>p</i> = 0.002). There was a significantly correlation found between RECK mRNA and poor survival after surgery. After treated by 5-Aza-CdR and TSA, we found that RECK mRNA induced different changes in 7721, Chang and Hep-G2 cells. And RECK demethylation also induced by epigenetic inhibitors.</p><p><b>Conclusion</b>: The results suggested that the hypermethylation may lead to promoter silencing of RECK mRNA and associated with poor survival in HCC.</p> ]]></description>  
<dc:creator>Changsong Zhang, Yang Ling, Chenghui Zhang, Yun Xu, Lu Gao, Rong Li, Jing Zhu, Lieying Fan, Lixin Wei</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>4</prism:number> 
  <prism:startingPage>451</prism:startingPage> 
  <prism:endingPage>458</prism:endingPage> 
  <prism:publicationDate>2012-3-3</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0442.htm</link> 
<title>Prognostic Values of Filamin-A Status for Topoisomerase II Poison Chemotherapy</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0442.htm</guid> 
<description><![CDATA[ <p>Filamin-A, also called Actin Binding Protein-280, is not only an essential component of the cytoskeleton networks, but also serves as the scaffold in various signaling networks. It has been shown that filamin-A facilitates DNA repair and filamin-A proficient cells are more resistant to ionizing radiation, bleomycin, and cisplatin. In this study, we assessed the role of filamin-A in modulating cancer cell sensitivity to Topo II poisons, including etoposide and doxorubicin. Intriguingly, we found that cells with filamin-A expression are more sensitive to Topo II poisons than those with defective filamin-A, and filamin-A proficient xenograft melanomas have better response to etoposide treatment than the filamin-A deficient tumors. This is associated with more potent induction of DNA double strand breaks (DSBs) by Topo II poisons in filamin-A proficient cells than the deficient cells. Although the expression of filamin-A enables cells a slightly stronger capability to repair DSB, the net outcome is that filamin-A proficient cells bear more DSBs due to the significantly enhanced DSB induction by Topo II poisons in these cells. We further found that filamin-A proficient cells have increased drug influx and decreased drug efflux, suggesting that filamin-A modulates the intra-cellular drug kinetics of Topo II poisons to facilitate the generation of DSB after Topo II poison exposure. These data suggest a novel function of filamin-A in regulating the pharmacokinetics of Topo II poisons, and that the status of filamin-A may be used as a prognostic marker for Topo II poisons based cancer treatments.</p> ]]></description>  
<dc:creator>Jingyin Yue, Shijie Lan, Changji Yuan, Zhiyuan Shen</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>4</prism:number> 
  <prism:startingPage>442</prism:startingPage> 
  <prism:endingPage>450</prism:endingPage> 
  <prism:publicationDate>2012-2-29</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0430.htm</link> 
<title>Hydrogen Sulfide Mitigates Cardiac Remodeling During Myocardial Infarction via Improvement of Angiogenesis</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0430.htm</guid> 
<description><![CDATA[ <p>Exogenous hydrogen sulfide (H2S) leads to down-regulation of inflammatory responses and provides myocardial protection during acute ischemia/reperfusion injury; however its role during chronic heart failure (CHF) due to myocardial infarction (MI) is yet to be unveiled. We previously reported that H2S inhibits antiangiogenic factors such, as endostatin and angiostatin, but a little is known about its effect on parstatin (a fragment of proteinase-activated receptor-1, PAR-1). We hypothesize that H2S inhibits parstatin formation and promotes VEGF activation, thus promoting angiogenesis and significantly limiting the extent of MI injury. To verify this hypothesis MI was created in 12 week-old male mice by ligation of left anterior descending artery (LAD). Sham surgery was performed except LAD ligation. After the surgery mice were treated with sodium hydrogen sulfide (30 &#956;mol/l NaHS, a donor for H2S, in drinking water) for 4 weeks. The LV tissue was analyzed for VEGF, flk-1 and flt-1, endostatin, angiostatin and parstatin. The expression of VEGF, flk-1 and flt-1 were significantly increased in treated mice while the level of endostatin, angiostatin and parstatin were decreased compared to in untreated mice. The echocardiography in mice treated with H2S showed the improvement of heart function compared to in untreated mice. The X-ray and Doppler blood flow measurements showed enhancement of cardiac-angiogenesis in mice treated with H2S. This observed cytoprotection was associated with an inhibition of anti-angiogenic proteins and stimulation of angiogenic factors. We established that administration of H2S at the time of MI ameliorated infarct size and preserved LV function during development of MI in mice. These results suggest that H2S is cytoprotective and angioprotective during evolution of MI.</p> ]]></description>  
<dc:creator>Natia Qipshidze, Naira Metreveli, Paras K. Mishra, David Lominadze, Suresh C. Tyagi</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>4</prism:number> 
  <prism:startingPage>430</prism:startingPage> 
  <prism:endingPage>441</prism:endingPage> 
  <prism:publicationDate>2012-2-28</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0418.htm</link> 
<title>Isolation and Identification of miRNAs in Jatropha curcas</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0418.htm</guid> 
<description><![CDATA[ <p>MicroRNAs (miRNAs) are small noncoding RNAs that play crucial regulatory roles by targeting mRNAs for silencing. To identify miRNAs in <i>Jatropha curcas </i>L<i>, </i>a bioenergy crop, cDNA clones from two small RNA libraries of leaves and seeds were sequenced and analyzed using bioinformatic tools. Fifty-two putative miRNAs were found from the two libraries, among them six were identical to known miRNAs and 46 were novel. Differential expression patterns of 15 miRNAs in root, stem, leave, fruit and seed were detected using quantitative real-time PCR. Ten miRNAs were highly expressed in fruit or seed, implying that they may be involved in seed development or fatty acids synthesis in seed. Moreover, 28 targets of the isolated miRNAs were predicted from a jatropha cDNA library database. The miRNA target genes were predicted to encode a broad range of proteins. Sixteen targets had clear BLASTX hits to the Uniprot database and were associated with genes belonging to the three major gene ontology categories of biological process, cellular component, and molecular function. Four targets were identified for JcumiR004. By silencing JcumiR004 primary miRNA, expressions of the four target genes were up-regulated and oil composition were modulated significantly, indicating diverse functions of JcumiR004.</p> ]]></description>  
<dc:creator>Chun Ming Wang, Peng Liu, Fei Sun, Lei Li, Peng Liu, Jian Ye, Gen Hua Yue</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>3</prism:number> 
  <prism:startingPage>418</prism:startingPage> 
  <prism:endingPage>429</prism:endingPage> 
  <prism:publicationDate>2012-2-28</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0406.htm</link> 
<title>Phenotypic Characterization of Osteoarthritic Osteocytes from the Sclerotic Zones: A Possible Pathological Role in Subchondral Bone Sclerosis</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0406.htm</guid> 
<description><![CDATA[ <p>Subchondral bone sclerosis is a well-recognised manifestation of osteoarthritis (OA). The osteocyte cell network is now considered to be central to the regulation of bone homeostasis; however, it is not known whether the integrity of the osteocyte cell network is altered in OA patients. The aim of this study was to investigate OA osteocyte phenotypic changes and its potential role in OA subchondral bone pathogenesis. The morphological and phenotypic changes of osteocytes in OA samples were investigated by micro-CT, SEM, histology, immunohistochemistry, TRAP staining, apoptosis assay and real-time PCR studies. We demonstrated that in OA subchondral bone, the osteocyte morphology was altered showing rough and rounded cell body with fewer and disorganized dendrites compared with the osteocytes in control samples. OA osteocyte also showed dysregulated expression of osteocyte markers, apoptosis, and degradative enzymes, indicating that the phenotypical changes in OA osteocytes were accompanied with OA subchondral bone remodelling (increased osteoblast and osteoclast activity) and increased bone volume with altered mineral content. Significant alteration of osteocytes identified in OA samples indicates a potential regulatory role of osteocytes in subchondral bone remodelling and mineral metabolism during OA pathogenesis.</p> ]]></description>  
<dc:creator>Anjali Jaiprakash, Indira Prasadam, Jian Q. Feng, Ying Liu, Ross Crawford, Yin Xiao</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>3</prism:number> 
  <prism:startingPage>406</prism:startingPage> 
  <prism:endingPage>417</prism:endingPage> 
  <prism:publicationDate>2012-2-27</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0394.htm</link> 
<title>Swainsonine Activates Mitochondria-mediated Apoptotic Pathway in Human Lung Cancer A549 Cells and Retards the Growth of Lung Cancer Xenografts</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0394.htm</guid> 
<description><![CDATA[ <p>Swainsonine (1, 2, 8-trihyroxyindolizidine, SW), a natural alkaloid, has been reported to exhibit anti-cancer activity on several mouse models of human cancer and human cancers <i>in vivo</i>. However, the mechanisms of SW-mediated tumor regression are not clear. In this study, we investigated the effects of SW on several human lung cancer cell lines<i> in vitro. </i>The results showed that SW significantly inhibited these cells growth through induction of apoptosis in different extent <i>in vitro</i>. Further studies showed that SW treatment up-regulated Bax, down-regulated Bcl-2 expression, promoted Bax translocation to mitochondria, activated mitochondria-mediated apoptotic pathway, which in turn caused the release of cytochrome c, the activation of caspase-9 and caspase-3, and the cleavage of poly (ADP-ribose) polymerase (PARP), resulting in A549 cell apoptosis. However, the expression of Fas, Fas ligand (FasL) or caspase-8 activity did not appear significant changes in the process of SW-induced apoptosis. Moreover, SW treatment inhibited Bcl-2 expression, promoted Bax translocation, cytochrome c release and caspase-3 activity in xenograft tumor cells, resulting in a significant decrease of tumor volume and tumor weight in the SW-treated xenograft mice groups in comparison to the control group. Taken together, this study demonstrated for the first time that SW inhibited A549 cancer cells growth through a mitochondria-mediated, caspase-dependent apoptotic pathway <i>in vitro</i> and <i>in vivo</i>.</p> ]]></description>  
<dc:creator>Zhaocai Li, Xingang Xu, Yong Huang, Li Ding, Zhisheng Wang, Gaoshui Yu, Dan Xu, Wei Li, Dewen Tong</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>3</prism:number> 
  <prism:startingPage>394</prism:startingPage> 
  <prism:endingPage>405</prism:endingPage> 
  <prism:publicationDate>2012-2-24</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0383.htm</link> 
<title>Interleukin-11 Promotes the Progress of Gastric Carcinoma via Abnormally Expressed Versican</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0383.htm</guid> 
<description><![CDATA[ <p>Versican, a ubiquitous component of the extracellular matrix (ECM), accumulates both in tumor stroma and cancer cells and is highly regulated by various cytokines. The aberrant expression of versican and its isoforms is known to modulate cell proliferation, differentiation, and migration, all of which are features of the invasion and metastasis of cancer; versican is also known to favour the homeostasis of the ECM. Interleukin-11 (IL-11) is an important cytokine that exhibits a wide variety of biological effects in gastric cancer development. Here, we analysed the expression of versican isoforms and found that the major isoforms expressed by both gastric carcinoma tissue and gastric cell lines were V0 and V1, and V1 was significantly higher in gastric carcinoma tissue. The treatment of the gastric cell lines AGS and MKN45 with rhIL-11 resulted in a significant increase in the expression of V0 and V1. Exogenous IL-11 increased migration in AGS and MKN45 cells, whereas these effects were reversed when the expression of V0 and V1 were abolished by siRNA targeting versican V0/V1. Collectively, these findings suggest that the abnormally expressed versican and its isoforms participate, at least in part, in the progress of gastric carcinoma triggered by IL-11.</p> ]]></description>  
<dc:creator>Zhenwei Zhang, Jianpeng Zhang, Lei Miao, Ke Liu, Shengsheng Yang, Chuanyong Pan, Binghua Jiao</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>3</prism:number> 
  <prism:startingPage>383</prism:startingPage> 
  <prism:endingPage>393</prism:endingPage> 
  <prism:publicationDate>2012-2-23</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0375.htm</link> 
<title>Polymorphic Allele of Human MRC1 Confer Protection against Tuberculosis in a Chinese Population</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0375.htm</guid> 
<description><![CDATA[ <p>Mannose receptor is a member of the C-type lectin receptor family involved in pathogen molecular-pattern recognition, and plays a critical role in shaping host immune response. Single nucleotide polymorphisms (SNPs) in the <i>MRC1</i> gene may affect expression levels and differences in the structure and function of proteins in different individuals, thereby affecting individual susceptibility to pulmonary tuberculosis. However, to date, <i>MRC1</i> polymorphisms associated with susceptibility to pulmonary tuberculosis have not yet been reported. The present study aimed to investigate potential associations of SNPs in the <i>MRC1</i> gene with pulmonary tuberculosis in a Chinese population. Six SNPs (G1186A, G1195A, T1212C, C1221G, C1303T and C1323T) in exon 7 of the <i>MRC1</i> gene were genotyped using the PCR and DNA sequencing methods in the pulmonary tuberculosis patients and the healthy controls. Linkage disequilibrium analysis was performed between polymorphic sites. The study found that the allele frequency of G1186A (rs34039386) of the <i>MRC1</i> gene in a Chinese population was higher in the pulmonary tuberculosis group than the healthy control group. There was a significant difference in frequency distribution between the two groups (<i>P</i> = 0.037; OR = 0.76; 95% CI, 0.58-0.98). Genotypic analysis also indicated that the AG genotypes in a Chinese population were significantly correlated with pulmonary tuberculosis (<i>P</i> &#60; 0.01; OR = 0.57; 95% CI, 0.37-0.87). After adjustment for age and gender, G1186A sites were found to be dominant (<i>P</i> &#60; 0.01; OR = 0.59; 95% CI, 0.40-0.87), over-dominant (<i>P</i> = 0.045; OR = 0.69; 95% CI, 0.47-0.99) and additive models (<i>P</i> = 0.041; OR = 0.76; 95% CI, 0.59-0.99) in association with pulmonary tuberculosis. But, no association was found between the other 5 SNPs (G1195A, T1212C, C1221G, C1303T and C1323T) and tuberculosis (<i>P</i> &#62; 0.05). This study is the first to report that genetic variants in the <i>MRC1</i> gene can be associated with pulmonary tuberculosis in a Chinese population, and may reduce the risk of infecting pulmonary tuberculosis. This also provides a new experimental basis to clarify the pathogenesis of pulmonary tuberculosis.</p> ]]></description>  
<dc:creator>Xing Zhang, Feng Jiang, Liliang Wei, Fujian Li, Jiyan Liu, Chong Wang, Menyuan Zhao, Tingting Jiang, Dandan Xu, Dapeng Fan, Xiaojun Sun, Ji-Cheng Li</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>3</prism:number> 
  <prism:startingPage>375</prism:startingPage> 
  <prism:endingPage>382</prism:endingPage> 
  <prism:publicationDate>2012-2-23</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0363.htm</link> 
<title>Protective Effects of Garlic Oil on Hepatocarcinoma Induced by N-Nitrosodiethylamine in Rats</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0363.htm</guid> 
<description><![CDATA[ <p>To investigate the protective effects and the possible mechanisms of garlic oil (GO) against N-nitrosodiethylamine (NDEA)-induced hepatocarcinoma in rats, Wistar rats were gavaged with GO (20 or 40 mg/kg) for 1 week, and then were gavaged with GO and NDEA (10 mg/kg) for the next 20 weeks. The changes of morphology, histology, the biochemical indices of serum, and DNA oxidative damage of liver were examined to assess the protective effects. Lipid peroxidation (LPO), antioxidant defense system, and apoptosis-related proteins were measured to investigate potential mechanisms. At the end of the study (21 weeks), GO administration significantly inhibited the increase of the nodule incidence and average nodule number per nodule-bearing liver induced by NDEA, improved hepatocellular architecture, and dramatically inhibited NDEA-induced elevation of serum biochemical indices (alanine aminotransferase , aspartate aminotransferase, alkaline phosphatase and gamma-glutamyl transpeptidase) and hepatic 8-hydroxy-2'-deoxyguanosine (8-OHdG) levels in a dose-dependent manner. The mechanistic studies demonstrated that GO counteracted NDEA-induced oxidative stress in rats illustrated by the restoration of glutathione (GSH), superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx), glutathione-S-transferase (GST) levels, and the reduction of the malondialdehyde (MDA) levels in liver. Furthermore, the mRNA and protein levels of Bcl-2, Bcl-xl, and&#946;-arrestin-2 were significantly decreased whereas those of Bax and caspase-3 were significantly increased. These data suggest that GO exhibited significant protection against NDEA-induced hepatocarcinogenesis, which might be related with the enhancement of the antioxidant activity and the induction of apoptosis.</p> ]]></description>  
<dc:creator>Cui-Li Zhang, Tao Zeng, Xiu-Lan Zhao, Li-Hua Yu, Zhen-Ping Zhu, Ke-Qin Xie</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>3</prism:number> 
  <prism:startingPage>363</prism:startingPage> 
  <prism:endingPage>374</prism:endingPage> 
  <prism:publicationDate>2012-2-22</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0353.htm</link> 
<title>Comparison of Protein Expression Profiles of Different Stages of Lymph Nodes Metastasis in Breast Cancer</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0353.htm</guid> 
<description><![CDATA[ <p>Breast cancer is the most common cancer among women worldwide. Breast cancer metastasis primarily happens through lymphatic system, where the extent of lymph node metastasis is the major factor influencing staging, prognosis and therapeutic decision of the disease. We aimed to study the protein expression changes in different N (regional lymph nodes) stages of breast cancer. Protein expression profiles of breast cancerous and adjacent normal tissues were mapped by proteomics approach that comprises of two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) and tandem mass spectrometry (LC-MS/MS) analysis. Calreticulin and tropomyosin alpha 3 chains were the common up-regulated proteins in N0, N1 and N2 stages of breast cancer. Potential biomarker for each N stage was HSP 70 for N0, 80 k protein H precursor and PDI for N1 stage while 78 kDa glucose-regulated protein was found useful for N2 stage. In addition, significant up-regulation of PDI A3 was detected only in the metastasized breast cancer. The up-regulation expression of these proteins in cancerous tissues can potentially use as indicators for diagnosis, treatment and prognosis of different N stages of breast cancer.</p> ]]></description>  
<dc:creator>Hui-Hua Lee, Chu-Ai Lim, Yew-Teik Cheong, Manjit Singh, Lay-Harn Gam</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>3</prism:number> 
  <prism:startingPage>353</prism:startingPage> 
  <prism:endingPage>362</prism:endingPage> 
  <prism:publicationDate>2012-2-20</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0344.htm</link> 
<title>U12-type Spliceosomal Introns of Insecta</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0344.htm</guid> 
<description><![CDATA[ <p>Most of eukaryotic genes are interrupted by introns that need to be removed from pre-mRNAs before they can perform their function. This is done by complex machinery called spliceosome. Many eukaryotes possess two separate spliceosomal systems that process separate sets of introns. The major (U2) spliceosome removes majority of introns, while minute fraction of intron repertoire is processed by the minor (U12) spliceosome. These two populations of introns are called U2-type and U12-type, respectively. The latter fall into two subtypes based on the terminal dinucleotides. The minor spliceosomal system has been lost independently in some lineages, while in some others few U12-type introns persist. We investigated twenty insect genomes in order to better understand the evolutionary dynamics of U12-type introns. Our work confirms dramatic drop of U12-type introns in <i>Diptera</i>, leaving these genomes just with a handful cases. This is mostly the result of intron deletion, but in a number of dipteral cases, minor type introns were switched to a major type, as well. Insect genes that harbor U12-type introns belong to several functional categories among which proteins binding ions and nucleic acids are enriched and these few categories are also overrepresented among these genes that preserved minor type introns in <i>Diptera</i>.</p> ]]></description>  
<dc:creator>Jessin Janice, Amit Pande, January Weiner, Chiao-Feng Lin, Wojciech Maka&#322;owski</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>3</prism:number> 
  <prism:startingPage>344</prism:startingPage> 
  <prism:endingPage>352</prism:endingPage> 
  <prism:publicationDate>2012-2-17</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0328.htm</link> 
<title>Gene Expression Profiling of the Cephalothorax and Eyestalk in Penaeus Monodon during Ovarian Maturation</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0328.htm</guid> 
<description><![CDATA[ <p>In crustaceans, a range of physiological processes involved in ovarian maturation occurs in organs of the cephalothorax including the hepatopancrease, mandibular and Y-organ. Additionally, reproduction is regulated by neuropeptide hormones and other proteins released from secretory sites within the eyestalk. Reproductive dysfunction in captive-reared prawns, <i>Penaeus monodon</i>, is believed to be due to deficiencies in these factors. In this study, we investigated the expression of gene transcripts in the cephalothorax and eyestalk from wild-caught and captive-reared animals throughout ovarian maturation using custom oligonucleotide microarray screening. We have isolated numerous transcripts that appear to be differentially expressed throughout ovarian maturation and between wild-caught and captive-reared animals. In the cephalothorax, differentially expressed genes included the 1,3-&#946;-D-glucan-binding high-density lipoprotein, 2/3-oxoacyl-CoA thiolase and vitellogenin. In the eyestalk, these include gene transcripts that encode a protein that modulates G-protein coupled receptor activity and another that encodes an architectural transcription factor. Each may regulate the expression of reproductive neuropeptides, such as the crustacean hyperglycaemic hormone and molt-inhibiting hormone. We could not identify differentially expressed transcripts encoding known reproductive neuropeptides in the eyestalk of either wild-caught or captive-reared prawns at any ovarian maturation stage, however, this result may be attributed to low relative expression levels of these transcripts. In summary, this study provides a foundation for the study of target genes involved in regulating penaeid reproduction.</p> ]]></description>  
<dc:creator>Philip Brady, Abigail Elizur, Richard Williams, Scott F. Cummins, Wayne Knibb</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>3</prism:number> 
  <prism:startingPage>328</prism:startingPage> 
  <prism:endingPage>343</prism:endingPage> 
  <prism:publicationDate>2012-2-9</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0310.htm</link> 
<title>An Anti-PCSK9 Antibody Reduces LDL-Cholesterol On Top Of A Statin And Suppresses Hepatocyte SREBP-Regulated Genes</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0310.htm</guid> 
<description><![CDATA[ <p>Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a promising therapeutic target for treating coronary heart disease. We report a novel antibody 1B20 that binds to PCSK9 with sub-nanomolar affinity and antagonizes PCSK9 function <i>in-vitro</i>. In CETP/LDLR-hemi mice two successive doses of 1B20, administered 14 days apart at 3 or 10 mpk, induced dose dependent reductions in LDL-cholesterol (&#8805; 25% for 7-14 days) that correlated well with the extent of PCSK9 occupancy by the antibody. In addition, 1B20 induces increases in total plasma antibody-bound PCSK9 levels and decreases in liver mRNA levels of SREBP-regulated genes PCSK9 and LDLR, with a time course that parallels decreases in plasma LDL-cholesterol (LDL-C). Consistent with this observation in mice, in statin-responsive human primary hepatocytes, 1B20 lowers PCSK9 and LDLR mRNA levels and raises serum steady-state levels of antibody-bound PCSK9. In addition, mRNA levels of several SREBP regulated genes involved in cholesterol and fatty-acid synthesis including ACSS2, FDPS, IDI1, MVD, HMGCR, and CYP51A1 were decreased significantly with antibody treatment of primary human hepatocytes. In rhesus monkeys, subcutaneous (SC) dosing of 1B20 dose-dependently induces robust LDL-C lowering (maximal &#126;70%), which is correlated with increases in target engagement and total antibody-bound PCSK9 levels. Importantly, a combination of 1B20 and Simvastatin in dyslipidemic rhesus monkeys reduced LDL-C more than either agent alone, consistent with a mechanism of action that predicts additive effects of anti-PCSK9 agents with statins. Our results suggest that antibodies targeting PCSK9 could provide patients powerful LDL lowering efficacy on top of statins, and lower cardiovascular risk.</p> ]]></description>  
<dc:creator>Liwen Zhang, Timothy McCabe, Jon H. Condra, Yan G. Ni, Laurence B. Peterson, Weirong Wang, Alison M. Strack, Fubao Wang, Shilpa Pandit, Holly Hammond, Dana Wood, Dale Lewis, Ray Rosa, Vivienne Mendoza, Anne Marie Cumiskey, Douglas G. Johns, Barbara C. Hansen, Xun Shen, Neil Geoghagen, Kristian Jensen, Lei Zhu, Karol Wietecha, Douglas Wisniewski, Lingyi Huang, Jing Zhang Zhao, Robin Ernst, Richard Hampton, Peter Haytko, Frances Ansbro, Shannon Chilewski, Jayne Chin, Lyndon J. Mitnaul, Andrea Pellacani, Carl P. Sparrow, Zhiqiang An, William Strohl, Brian Hubbard, Andrew S. Plump, Daniel Blom, Ayesha Sitlani</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>3</prism:number> 
  <prism:startingPage>310</prism:startingPage> 
  <prism:endingPage>327</prism:endingPage> 
  <prism:publicationDate>2012-2-9</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0298.htm</link> 
<title>Pretreatment of Cisplatin in Recipients Attenuates Post-Transplantation Pancreatitis in Murine Model</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0298.htm</guid> 
<description><![CDATA[ <p>Pancreas transplantation is the definite treatment for type 1 diabetes that enables the achievement of long-term normoglycemia and insulin independence. However Post-Transplantation Pancreatitis (PTP) due to ischemia reperfusion (IR) injury and preservation is a major complication in pancreas transplantation. Owning the potential anti-inflammatory effect of Cisplatin (Cis) in liver IR injury, we have examined if Cis could attenuate PTP using a murine model. We found that Cis is able to prevent inflammatory response in PTP. Pretreatment of Cis in recipient mice reduce the impairments of the grafts and hyperamylasimea in the recipients. We documented that the protective mechanism of Cis in PTP involves improvement of microcirculation, reduction of the mononuclear cellular infiltration and apoptosis, suppression of inflammatory cytokine-cascade and inhibition of translocation of high-motility group box protein-1 (HMGB-1) from nucleus to cytoplasm. In short, our study demonstrated that pretreatment of Cis in recipients may reduce the onset of PTP in pancreas transplantation.</p> ]]></description>  
<dc:creator>Sheng Yan, Yuan Ding, Fei Sun, Zhongjie Lu, Liang Xue, Xiangyan Liu, Mingqi Shuai, Chen Fang, Yan Wang, Hui Cheng, Lin Zhou, Ming H Zheng, Shusen Zheng</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>3</prism:number> 
  <prism:startingPage>298</prism:startingPage> 
  <prism:endingPage>309</prism:endingPage> 
  <prism:publicationDate>2012-2-1</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0289.htm</link> 
<title>Activated &#946;-catenin Forces N2A Cell-derived Neurons Back to Tumor-like Neuroblasts and Positively Correlates with a Risk for Human Neuroblastoma</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0289.htm</guid> 
<description><![CDATA[ <p>Neuroblastoma is an embryonic malignancy arising from neuroblasts. The mechanisms that regulate the origination of neuroblastoma are still not very clear. In this study, we revealed that 6-bromoindirubin 3'-oxime (BIO), a specific GSK-3&#946; inhibitor, promoted N2A cells-derived neurons to become tumor-like neuroblasts. Moreover, constitutively activated &#946;-catenin (S33Y) also promoted this process, whereas, silencing endogenous expression of &#946;-catenin abolished BIO-induced effects. These results implicated the potential relationship between the Wnt/&#946;-catenin signaling and neuroblastoma formation. Indeed, we found that the amount of &#946;-catenin in nucleus, which indicated the activation of Wnt/&#946;-catnin signaling, was accumulated in human neuroblastoma specimens and positively correlated with clinical risk of neuroblastoma. These results give us a new sight into the neuroblastoma initiation and progression, and provide a potential drug target for neuroblastoma treatment.</p> ]]></description>  
<dc:creator>Feng Zhi, Guangming Gong, Yan Xu, Yan Zhu, Die Hu, Yilin Yang, Yiqiao Hu</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>2</prism:number> 
  <prism:startingPage>289</prism:startingPage> 
  <prism:endingPage>297</prism:endingPage> 
  <prism:publicationDate>2012-1-23</prism:publicationDate> 
<prism:section>Short Research Communication</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0272.htm</link> 
<title>TGF-&#946; and BMP Signaling in Osteoblast Differentiation and Bone Formation</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0272.htm</guid> 
<description><![CDATA[ <p>Transforming growth factor-beta (TGF-&#946;)/bone morphogenic protein (BMP) signaling is involved in a vast majority of cellular processes and is fundamentally important throughout life. TGF-&#946;/BMPs have widely recognized roles in bone formation during mammalian development and exhibit versatile regulatory functions in the body. Signaling transduction by TGF-&#946;/BMPs is specifically through both canonical Smad-dependent pathways (TGF-&#946;/BMP ligands, receptors and Smads) and non-canonical Smad-independent signaling pathway (<i>e.g.</i> p38 mitogen-activated protein kinase pathway, MAPK). Following TGF-&#946;/BMP induction, both the Smad and p38 MAPK pathways converge at the Runx2 gene to control mesenchymal precursor cell differentiation. The coordinated activity of Runx2 and TGF-&#946;/BMP-activated Smads is critical for formation of the skeleton. Recent advances in molecular and genetic studies using gene targeting in mice enable a better understanding of TGF-&#946;/BMP signaling in bone and in the signaling networks underlying osteoblast differentiation and bone formation. This review summarizes the recent advances in our understanding of TGF-&#946;/BMP signaling in bone from studies of genetic mouse models and human diseases caused by the disruption of TGF-&#946;/BMP signaling. This review also highlights the different modes of cross-talk between TGF-&#946;/BMP signaling and the signaling pathways of MAPK, Wnt, Hedgehog, Notch, and FGF in osteoblast differentiation and bone formation.</p> ]]></description>  
<dc:creator>Guiqian Chen, Chuxia Deng, Yi-Ping Li</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>2</prism:number> 
  <prism:startingPage>272</prism:startingPage> 
  <prism:endingPage>288</prism:endingPage> 
  <prism:publicationDate>2012-1-21</prism:publicationDate> 
<prism:section>Review</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0265.htm</link> 
<title>Measurement of Hepatic Protein Fractional Synthetic Rate with Stable Isotope Labeling Technique in Thapsigargin Stressed HepG2 Cells</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0265.htm</guid> 
<description><![CDATA[ <p>Severe burn-induced liver damage and dysfunction is associated with endoplasmic reticulum (ER) stress. ER stress has been shown to regulate global protein synthesis. In the current study, we induced ER stress <i>in vitro</i> and estimated the effect of ER stress on hepatic protein synthesis. The aim was two-fold: (1) to establish an <i>in vitro</i> model to isotopically measure hepatic protein synthesis and (2) to evaluate protein fractional synthetic rate (FSR) in response to ER stress. Human hepatocellular carcinoma cells (HepG2) were cultured in medium supplemented with stable isotopes 1,2-<sup>13</sup>C<sub>2</sub>-glycine and L-[ring-<sup>13</sup>C<sub>6</sub>]phenylalanine. ER stress was induced by exposing the cells to 100 nM of thapsigargin (TG). Cell content was collected from day 0 to 14. Alterations in cytosolic calcium were measured by calcium imaging and ER stress markers were confirmed by Western blotting. The precursor and product enrichments were detected by GC-MS analysis for FSR calculation. We found that the hepatic protein FSR were 0.97&#177;0.02 and 0.99&#177;0.05%/hr calculated from 1,2-<sup>13</sup>C<sub>2</sub>-glycine and L-[ring-<sup>13</sup>C<sub>6</sub>]phenylalanine, respectively. TG depleted ER calcium stores and induced ER stress by upregulating p-IRE-1 and Bip. FSR dramatically decreased to 0.68&#177;0.03 and 0.60&#177;0.06%/hr in the TG treatment group (p&#60;0.05, vs. control). TG-induced ER stress inhibited hepatic protein synthesis. The stable isotope tracer incorporation technique is a useful method for studying the effects of ER stress on hepatic protein synthesis.</p> ]]></description>  
<dc:creator>Juquan Song, Xiao-jun Zhang, Darren Boehning, Natasha C. Brooks, David N. Herndon, Marc G. Jeschke</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>2</prism:number> 
  <prism:startingPage>265</prism:startingPage> 
  <prism:endingPage>271</prism:endingPage> 
  <prism:publicationDate>2012-1-20</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0258.htm</link> 
<title>An Updated Nomenclature for Keratin-Associated Proteins (KAPs)</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0258.htm</guid> 
<description><![CDATA[ <p>Most protein in hair and wool is of two broad types: keratin intermediate filament-forming proteins (commonly known as keratins) and keratin-associated proteins (KAPs). Keratin nomenclature was reviewed in 2006, but the KAP nomenclature has not been revised since 1993. Recently there has been an increase in the number of KAP genes (<i>KRTAP</i>s) identified in humans and other species, and increasingly reports of variation in these genes. We therefore propose that an updated naming system is needed to accommodate the complexity of the KAPs. It is proposed that the system is founded in the previous nomenclature, but with the abbreviation sp-KAPm-nL*x for KAP proteins and sp<i>-KRTAPm-n(p/L)</i>*<i>x</i> for KAP genes. In this system &#8220;sp&#8221; is a unique letter-based code for different species as described by the protein knowledge-based UniProt. &#8220;m&#8221; is a number identifying the gene or protein family, &#8220;n&#8221; is a constituent member of that family, &#8220;p&#8221; signifies a pseudogene if present, &#8220;L&#8221; if present signifies &#8220;like&#8221; and refers to a temporary &#8220;place-holder&#8221; until the family is confirmed and &#8220;x&#8221; signifies a genetic variant or allele. We support the use of non-italicised text for the proteins and italicised text for the genes.</p><p>This nomenclature is not that different to the existing system, but it includes species information and also describes genetic variation if identified, and hence is more informative. For example, GenBank sequence JN091630 would historically have been named <i>KRTAP7-1</i> for the gene and KAP7-1 for the protein, but with the proposed nomenclature would be SHEEP-<i>KRTAP7-1*A</i> and SHEEP-KAP7-1*A for the gene and protein respectively. This nomenclature will facilitate more efficient storage and retrieval of data and define a common language for the KAP proteins and genes from all mammalian species.</p> ]]></description>  
<dc:creator>Hua Gong, Huitong Zhou, Grant W. McKenzie, Zhidong Yu, Stefan Clerens, Jolon M. Dyer, Jeffrey E. Plowman, Mathew W. Wright, Reena Arora, C. Simon Bawden, Yulin Chen, Jinquan Li, Jonathan G. H. Hickford</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>2</prism:number> 
  <prism:startingPage>258</prism:startingPage> 
  <prism:endingPage>264</prism:endingPage> 
  <prism:publicationDate>2012-1-12</prism:publicationDate> 
<prism:section>Mini-review</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0249.htm</link> 
<title>Interleukin-22 Ameliorates Cerulein-Induced Pancreatitis in Mice by Inhibiting the Autophagic Pathway</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0249.htm</guid> 
<description><![CDATA[ <p>Pancreatitis occurs when digestive enzymes are activated in the pancreas. Severe pancreatitis has a 10-30% mortality rate. No specific treatments for pancreatitis exist now. Here, we discovered that interleukin-22 (IL-22) may have therapeutic potential in treating acute and chronic pancreatitis. Wild-type and IL-22 knockout mice were equally susceptible to cerulein-induced acute and chronic pancreatitis, whereas liver-specific IL-22 transgenic mice were completely resistant to cerulein-induced elevation of serum digestive enzymes, pancreatic necrosis and apoptosis, and inflammatory cell infiltration. Treatment of wild-type mice with recombinant IL-22 or adenovirus IL-22 markedly attenuated the severity of cerulein-induced acute and chronic pancreatitis. Mechanistically, we show that the protective effect of IL-22 on pancreatitis was mediated via the induction of Bcl-2 and Bcl-X<sub>L</sub>, which bind to Beclin-1 and subsequently inhibit autophagosome formation to ameliorate pancreatitis. In conclusion, IL-22 ameliorates cerulein-induced pancreatitis by inhibiting the autophagic pathway. IL-22 could be a promising therapeutic drug to treat pancreatitis.</p> ]]></description>  
<dc:creator>Dechun Feng, Ogyi Park, Svetlana Radaeva, Hua Wang, Shi Yin, Xiaoni Kong, Mingquan Zheng, Sam Zakhari, Jay K. Kolls, Bin Gao</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>2</prism:number> 
  <prism:startingPage>249</prism:startingPage> 
  <prism:endingPage>257</prism:endingPage> 
  <prism:publicationDate>2012-1-6</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0236.htm</link> 
<title>Simvastatin Modulates Remodeling of Kv4.3 Expression in Rat Hypertrophied Cardiomyocytes</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0236.htm</guid> 
<description><![CDATA[ <p><b>Objectives:</b> Hypertrophy has been shown to be associated with arrhythmias which can be caused by abnormal remodeling of the Kv4-family of transient potassium channels. Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase (statins) have recently been shown to exert pleiotropic protective effects in cardiovascular diseases, including anti-arrhythmias. It is hypothesized that remodeling of Kv4.3 occurs in rat hypertrophied cardiomyocytes and is regulated by simvastatin.</p><p><b>Methods: </b>Male Sprague-Dawley rats and neonatal rat ventricular myocytes (NRVMs) underwent abdominal aortic banding (AAB) for 7 weeks and angiotensin II (AngII) treatment, respectively, to induce cardiac hypertrophy. Kv4.3 expression by NRVMs and myocardium (subepicardial and subendocardial) in the left ventricle was measured. The transient outward potassium current (<i>I</i><sub>to</sub>) of NRVMs was recorded using a whole-cell patch-clamp method.</p><p><b>Results:</b> Expression of the Kv4.3 transcript and protein was significantly reduced in myocardium (subepicardial and subendocardial) in the left ventricle and in NRVMs. Simvastatin partially prevented the reduction of Kv4.3 expression in NRVMs and subepicardial myocardium but not in the subendocardial myocardium. Hypertrophied NRVMs exhibited a significant reduction in the <i>I</i><sub>to</sub> current and this effect was partially reversed by simvastatin.</p><p><b>Conclusions:</b> Simvastatin alleviated the reduction of Kv4.3 expression, <i>I</i><sub>to</sub> currents in hypertrophied NRVMs and alleviated the reduced Kv4.3 expression in subepicardial myocardium from the hypertrophied left ventricle. It can be speculated that among the pleiotropic effects of simvastatin, the anti-arrhythmia effect is partly mediated by its effect on Kv4.3.</p> ]]></description>  
<dc:creator>Feifei Su, Miaoqian Shi, Zhiqiang Yan, Dongbo Ou, Juntang Li, Zifan Lu, Qiangsun Zheng</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>2</prism:number> 
  <prism:startingPage>236</prism:startingPage> 
  <prism:endingPage>248</prism:endingPage> 
  <prism:publicationDate>2012-1-6</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0228.htm</link> 
<title>The Pro-inflammatory Role of TGF&#946;1: A Paradox?</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0228.htm</guid> 
<description><![CDATA[ <p>TGF&#946;1 was initially identified as a potent chemotactic cytokine to initiate inflammation, but the autoimmune phenotype seen in TGF&#946;1 knockout mice reversed the dogma of TGF&#946;1 being a pro-inflammatory cytokine to predominantly an immune suppressor. The discovery of the role of TGF&#946;1 in Th17 cell activation once again revealed the pro-inflammatory effect of TGF&#946;1. We developed K5.TGF&#946;1 mice with latent human TGF&#946;1 overexpression targeted to epidermal keratinocytes by keratin 5. These transgenic mice developed significant skin inflammation. Further studies revealed that inflammation severity correlated with switching TGF&#946;1 transgene expression on and off, and genome wide expression profiling revealed striking similarities between K5.TGF&#946;1 skin and human psoriasis, a Th1/Th17-associated inflammatory skin disease. Our recent study reveals that treatments alleviating inflammatory skin phenotypes in this mouse model reduced Th17 cells, and antibodies against IL-17 also lessen the inflammatory phenotype. Examination of inflammatory cytokines/chemokines affected by TGF&#946;1 revealed predominantly Th1-, Th17-related cytokines in K5.TGF&#946;1 skin. However, the finding that K5.TGF&#946;1 mice also express Th2-associated inflammatory cytokines under certain pathological conditions raises the possibility that deregulated TGF&#946; signaling is involved in more than one inflammatory disease. Furthermore, activation of both Th1/Th17 cells and regulatory T cells (Tregs) by TGF&#946;1 reversely regulated by IL-6 highlights the dual role of TGF&#946;1 in regulating inflammation, a dynamic, context and organ specific process. This review focuses on the role of TGF&#946;1 in inflammatory skin diseases.</p> ]]></description>  
<dc:creator>Gangwen Han, Fulun Li, Tej Pratap Singh, Peter Wolf, Xiao-Jing Wang</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>2</prism:number> 
  <prism:startingPage>228</prism:startingPage> 
  <prism:endingPage>235</prism:endingPage> 
  <prism:publicationDate>2012-1-1</prism:publicationDate> 
<prism:section>Review</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0214.htm</link> 
<title>Contrasting Cellularity and Fatty Acid Composition in Fat Depots from Alentejana and Barros&#227; Bovine Breeds Fed High and Low Forage Diets</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0214.htm</guid> 
<description><![CDATA[ <p>During the finishing phase of bovines, large amounts of subcutaneous and visceral fats are deposited leading to production inefficiencies with major impact on meat quality. A better understanding of the cellularity features of the main fat depots could provide strategies for adipose tissue manipulation. This study assessed the effect of feeding diets with distinct forage to concentrate ratios on the cellularity of two fat depots of beef cattle and their implications on the fatty acid profile. Thus, two phylogenetically distant Portuguese bovine breeds, Alentejana and Barros&#227;, were selected. The results did not show differences in subcutaneous fat deposition nor in visceral fat depots partitioning. Plasma adipokines concentration failed to show a consistent relationship with fatness, as leptin remained constant in all experimental groups, whereas interleukin-6 was influenced by breed. Fat depot seems to determine the area and number of adipocytes, with larger adipocytes and a lower number of cells in subcutaneous fat than in mesenteric fat. Neither breed nor diet influenced adipocytes area and number. The contents of total fatty acids, partial sums of fatty acids and conjugated linoleic acid isomeric profile were affected by breed and fat depot. The incorporation of saturated fatty acids (SFA), <i>trans</i> fatty acids, polyunsaturated fatty acids (PUFA) and branched chain fatty acids (BCFA) was higher in mesenteric fat depot, whereas subcutaneous fat depot had greater percentages of monounsaturated fatty acids (MUFA). In addition, SFA and MUFA proportions seem to be breed-related. In spite of the less relevant role of diet, the percentages of PUFA and BCFA were influenced by this factor. Under these experimental conditions, the effect of fat depot on cellularity and fatty acid composition prevails over breed or diet, as reinforced by the principal component analysis.</p> ]]></description>  
<dc:creator>Ana S.H. Costa, Paula A. Lopes, Marta Estev&#227;o, Susana V. Martins, Susana P. Alves, Rui M.A. Pinto, Hugo Pissarra, Jorge J. Correia, M&#225;rio Pinho, Carlos M.G.A. Fontes, Jos&#233; A.M. Prates</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>2</prism:number> 
  <prism:startingPage>214</prism:startingPage> 
  <prism:endingPage>227</prism:endingPage> 
  <prism:publicationDate>2012-1-1</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0195.htm</link> 
<title>TGF&#946; Signaling and Cardiovascular Diseases</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0195.htm</guid> 
<description><![CDATA[ <p>Transforming growth factor &#946; (TGF&#946;) family members are involved in a wide range of diverse functions and play key roles in embryogenesis, development and tissue homeostasis. Perturbation of TGF&#946; signaling may lead to vascular and other diseases. <i>In vitro</i> studies have provided evidence that TGF&#946; family members have a wide range of diverse effects on vascular cells, which are highly dependent on cellular context. Consistent with these observations genetic studies in mice and humans showed that TGF&#946; family members have ambiguous effects on the function of the cardiovascular system. In this review we discuss the recent advances on TGF&#946; signaling in (cardio)vascular diseases, and describe the value of TGF&#946; signaling as both a disease marker and therapeutic target for (cardio)vascular diseases.</p> ]]></description>  
<dc:creator>Evangelia Pardali, Peter ten Dijke</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>2</prism:number> 
  <prism:startingPage>195</prism:startingPage> 
  <prism:endingPage>213</prism:endingPage> 
  <prism:publicationDate>2012-1-1</prism:publicationDate> 
<prism:section>Review</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0187.htm</link> 
<title>The Adhesion Modulating Properties of Tenascin-W</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0187.htm</guid> 
<description><![CDATA[ <p>Tenascins are extracellular matrix glycoproteins associated with cell motility, proliferation and differentiation. Tenascin-C inhibits cell spreading by binding to fibronectin; tenascin-R and tenascin-X also have anti-adhesive properties in vitro. Here we have studied the adhesion modulating properties of the most recently characterized tenascin, tenascin-W. C2C12 cells, a murine myoblast cell line, will form broad lamellipodia with stress fibers and focal adhesion complexes after culture on fibronectin. In contrast, C2C12 cells cultured on tenascin-W fail to spread and form stress fibers or focal adhesion complexes, and instead acquire a multipolar shape with short, actin-tipped pseudopodia. The same stellate morphology is observed when C2C12 cells are cultured on a mixture of fibronectin and tenascin-W, or on fibronectin in the presence of soluble tenascin-W. Tenascin-W combined with fibronectin also inhibits the spreading of mouse embryo fibroblasts when compared with cells cultured on fibronectin alone. The similarity between the adhesion modulating effects of tenascin-W and tenascin-C in vitro led us to study the possibility of tenascin-W compensating for tenascin-C in tenascin-C knockout mice, especially during epidermal wound healing. Dermal fibroblasts harvested from a tenascin-C knockout mouse express tenascin-W, but dermal fibroblasts taken from a wild type mouse do not. However, there is no upregulation of tenascin-W in the dermis of tenascin-C knockout mice, or in the granulation tissue of skin wounds in tenascin-C knockout animals. Similarly, tenascin-X is not upregulated in early wound granulation tissue in the tenascin-C knockout mice. Thus, tenascin-W is able to inhibit cell spreading in vitro and it is upregulated in dermal fibroblasts taken from the tenascin-C knockout mouse, but neither it nor tenascin-X are likely to compensate for missing tenascin-C during wound healing.</p> ]]></description>  
<dc:creator>Florence Brellier, Enrico Martina, Matthias Chiquet, Jacqueline Ferralli, Michael van der Heyden, Gertraud Orend, Johannes C. Schittny, Ruth Chiquet-Ehrismann, Richard P. Tucker</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>2</prism:number> 
  <prism:startingPage>187</prism:startingPage> 
  <prism:endingPage>194</prism:endingPage> 
  <prism:publicationDate>2011-12-20</prism:publicationDate> 
<prism:section>Short Research Communication</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0171.htm</link> 
<title>The Murine Caecal MicroRNA Signature Depends on the Presence of the Endogenous Microbiota</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0171.htm</guid> 
<description><![CDATA[ <p>The intestinal messenger RNA expression signature is affected by the presence and composition of the endogenous microbiota, with effects on host physiology. The intestine is also characterized by a distinctive micronome. However, it is not known if microbes also impact intestinal gene expression epigenetically. We investigated if the murine caecal microRNA expression signature depends on the presence of the microbiota, and the potential implications of this interaction on intestinal barrier function. Three hundred and thirty four microRNAs were detectable in the caecum of germ-free and conventional male mice and 16 were differentially expressed, with samples from the two groups clustering separately based on their expression patterns. Through a combination of computational and gene expression analyses, including the use of our curated list of 527 genes involved in intestinal barrier regulation, 2,755 putative targets of modulated microRNAs were identified, including 34 intestinal barrier-related genes encoding for junctional and mucus layer proteins and involved in immune regulation. This study shows that the endogenous microbiota influences the caecal microRNA expression signature, suggesting that microRNA modulation is another mechanism through which commensal bacteria impact the regulation of the barrier function and intestinal homeostasis. Through microRNAs, the gut microbiota may impinge a much larger number of genes than expected, particularly in diseases where its composition is altered. In this perspective, abnormally expressed microRNAs could be considered as novel therapeutic targets.</p> ]]></description>  
<dc:creator>Natasha Singh, Elize A. Shirdel, Levi Waldron, Regan-Heng Zhang, Igor Jurisica, Elena M. Comelli</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>2</prism:number> 
  <prism:startingPage>171</prism:startingPage> 
  <prism:endingPage>186</prism:endingPage> 
  <prism:publicationDate>2011-12-19</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0159.htm</link> 
<title>The Olfactory Co-receptor Orco from the Migratory Locust (Locusta migratoria) and the Desert Locust (Schistocerca gregaria): Identification and Expression pattern</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0159.htm</guid> 
<description><![CDATA[ <p>In locusts, olfaction plays a crucial role for initiating and controlling behaviours, including food seeking and aggregation with conspecifics, which underlie the agricultural pest capacity of the animals. In this context, the molecular basis of olfaction in these insects is of particular interest. Here, we have identified genes of two orthopteran species, <i>Locusta migratoria</i> and <i>Schistocera gregaria</i>, which encode the olfactory receptor co-receptor (Orco). It was found that the sequences of LmigOrco and SgreOrco share a high degree of identity to each other and also to Orco proteins from different insect orders. The Orco-expressing cells in the antenna of <i>S. gregaria</i> and <i>L. migratoria</i> were visualized by in situ hybridization. Orco expression could be assigned to clusters of cells in sensilla basiconica and few cells in sensilla trichodea, most likely representing olfactory sensory neurons. No Orco-positive cells were detected in sensilla coeloconica and sensilla chaetica. Orco expression was found already in all nymphal stages and was verified in some other tissues which are equipped with chemosensory hairs (mouthparts, tarsi, wings). Together, the results support the notion for a decisive role of Orco in locust olfaction.</p> ]]></description>  
<dc:creator>Ying Yang, J&#252;rgen Krieger, Long Zhang, Heinz Breer</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>2</prism:number> 
  <prism:startingPage>159</prism:startingPage> 
  <prism:endingPage>170</prism:endingPage> 
  <prism:publicationDate>2011-12-13</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0150.htm</link> 
<title>Matrine Inhibits Pacing Induced Atrial Fibrillation by Modulating IKM3 and ICa-L</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0150.htm</guid> 
<description><![CDATA[ <p><i>Aim:</i> To elucidate the protective effects of Matrine on atrial fibrillation (AF) induced by electric pacing in mice and underlying molecular and ion channel mechanisms.</p><p><i>Methods:</i> AF was introduced by electric pacing in mice and the incidence and duration of AF were evaluated. Functional expression of M<sub>3</sub> receptor (M<sub>3</sub>-R) and Cav1.2 were explored by western and Real-time PCR, action potential (AP) and the density of (I<sub>KM3</sub>) L-type calcium channel (I<sub>Ca-L</sub>) were both recorded using whole-cell patch in isolated atrial cardiomyocytes.</p><p><i>Results:</i> In control group, incidence and duration of AF induced by electric pacing were 50 &#177; 17% and 3.68 &#177; 1.84 s, respectively; after application of carbachol 50 &#181;g/kg both incidence and duration of AF were significantly increased to 86 &#177; 24% and 65.2 &#177; 29.0 s. Compared with control group, pretreatment of Matrine for 15 days significantly reduced AF incidence and duration in dose-dependent manner. Atrial membrane-protein expression of M<sub>3</sub>-R was decreased and membrane Cav1.2 expression was up-regulated. In single Matrine-treated atrial cardiomyocyte the density of I<sub>KM3</sub> was significantly decreased by 39% as well compared with control group, <i>P</i> &#60; 0.05, whereas, I<sub>Ca-L</sub> density of atrium was increased by 40%.</p><p><i>Conclusion:</i> These data demonstrated at the first time that the anti-AF effects of Matrine may due, at least in part, to down-regulation of I<sub>KM3</sub> density and M<sub>3</sub>-R expression and up-regulation of I<sub>Ca-L </sub>density and &#945;1C/Cav1.2 expression.</p> ]]></description>  
<dc:creator>Yuhong Zhou, Wei Xu, Ruyi Han, Jiaying Zhou, Zhenwei Pan, Huo Rong, Junnan Li, Changqing Xu, Guofen Qiao, Yanjie Lu</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>150</prism:startingPage> 
  <prism:endingPage>158</prism:endingPage> 
  <prism:publicationDate>2011-12-9</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0139.htm</link> 
<title>Altered Antioxidant Status and Increased Lipid Per-Oxidation in Seminal Plasma of Tunisian Infertile Men</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0139.htm</guid> 
<description><![CDATA[ <p>Human seminal plasma is a natural reservoir of antioxidants that protect spermatozoa from oxidative damages. There is evidence in literature supports the fact that impairments in seminal antioxidant and lipid per-oxidation status play important roles in the physiopathology of male infertility. Our present study forms the first one which was carried out in Tunisia. We evaluated the antioxidant status in the seminal plasma of 120 infertile men programmed to In Vitro Fertilization (IVF) for the first tentative. Patients were characterized by an idiopathic infertility. They were divided into three groups: normozoospermics who were considered as controls (n=40), asthenozoospermics (Astheno; n=45) and oligoasthenoteratozoospermics (OAT; n=35). Seminal activities of superoxide dismutase (SOD) and glutathione peroxidase (GPX) and the levels of glutathione (GSH), zinc (Zn) and malondialdehyde (MDA) were measured. With the significant increase of the seminal activities of SOD and GPX in normozoospermics group, there were positive correlations observed between this enzymes and sperm quality. Also, significant elevated rates of seminal zinc and GSH were observed in control group, but there was contradictory associations reflecting the effects of these antioxidants on semen parameters. However, we noted significant increase of MDA levels in groups with abnormal seminogram. We showed negative associations between this per-oxidative marker and sperm parameters. These results obviously suggested that impairment on seminal antioxidants is an important risk factor for low sperm quality associated to idiopathic infertility and as a result can lead to poor IVF outcome.</p> ]]></description>  
<dc:creator>Fatma Atig, Monia Raffa, Habib Ben Ali, Kerkeni Abdelhamid, Ali Saad, Mounir Ajina</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>139</prism:startingPage> 
  <prism:endingPage>149</prism:endingPage> 
  <prism:publicationDate>2011-12-8</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0125.htm</link> 
<title>Molecular Cloning and Characterization of Ecdysone oxidase and 3-dehydroecdysone-3&#945;-reductase Involved in the Ecdysone Inactivation Pathway of Silkworm, Bombyx mori</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0125.htm</guid> 
<description><![CDATA[ <p>Molting hormone (ecdysteroid) is one of the most important hormones in insects. The synthesis and inactivation of the ecdysteroid regulate the developmental process of insects. A major pathway of ecdysone inactivation is that ecdysone is converted to 3-dehydroecdysone, and then further to 3-epiecdysone in insects. Two enzymes (ecdysone oxidase: EO and 3DE-3&#945;-reductase) participate in this pathway. In this study, based on the previously characterized cDNAs in Spodoptera<i> littoralis</i>, we cloned and characterized <i>EO</i> and <i>3DE-3&#945;-reductase</i> genes in the silkworm, <i>Bombyx mori</i>. The heterologously expressed proteins of the two genes in yeast showed the ecdysone oxidase and 3DE-3&#945;-reductase activities, respectively<i>. </i>Expression of <i>BmEO</i> was only detected in the midgut at transcriptional and translational levels. We also localized EO within the midgut goblet cell cavities. For <i>Bm3DE-3&#945;-reductase</i> gene, RT-PCR and western blot showed that it was expressed in the midgut and the Malpighian tubules. Moreover, we localized 3DE-3&#945;-reductase within the midgut goblet cell cavities and the cytosol of principal cells of the Malpighian tubules. These two genes have similar expression profiles during different developmental stages. Both genes were highly expressed at the beginning of the 5<sup>th</sup> instar, and remained a relative low level during the feeding stage, and then were highly expressed at the wandering stage. All these results showed that the profiles of the two genes were well correlated with the ecdysteroid titer. The functional characterization of the enzymes participating in ecdysone inactivation in the silkworm provides hints for the artificial regulation of the silkworm development and biological control of pests.</p> ]]></description>  
<dc:creator>Wei Sun, Yi-Hong Shen, Deng-Wei Qi, Zhong-Huai Xiang, Ze Zhang</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>125</prism:startingPage> 
  <prism:endingPage>138</prism:endingPage> 
  <prism:publicationDate>2011-12-8</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0124.htm</link> 
<title>Correction: Molecular Characterization of Transcriptome-wide Interactions between Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus and Porcine Alveolar Macrophages in vivo</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0124.htm</guid> 
<description><![CDATA[  ]]></description>  
<dc:creator>Ping Zhou, Shanli Zhai, Xiang Zhou, Ping Lin, Tengfei Jiang, Xueying Hu, Yunbo Jiang, Bin Wu, Qingde Zhang, Xuewen Xu, Jin-ping Li, Bang Liu</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>124</prism:startingPage> 
  <prism:endingPage>124</prism:endingPage> 
  <prism:publicationDate>2011-12-1</prism:publicationDate> 
<prism:section>Erratum</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0118.htm</link> 
<title>Immune-related MicroRNAs are Abundant in Breast Milk Exosomes</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0118.htm</guid> 
<description><![CDATA[ <p>Breast milk is a complex liquid rich in immunological components that affect the development of the infant's immune system. Exosomes are membranous vesicles of endocytic origin that are found in various body fluids and that can mediate intercellular communication. MicroRNAs (miRNAs), a well-defined group of non-coding small RNAs, are packaged inside exosomes in human breast milk. Here, we identified 602 unique miRNAs originating from 452 miRNA precursors (pre-miRNAs) in human breast milk exosomes using deep sequencing technology. We found that, out of 87 well-characterized immune-related pre-miRNAs, 59 (67.82%) are presented and enriched in breast milk exosomes (<i>P</i> &#60; 10<sup>-16</sup>, <i>&#967;</i><sup>2</sup> test). In addition, compared with exogenous synthetic miRNAs, these endogenous immune-related miRNAs are more resistant to relatively harsh conditions. It is, therefore, tempting to speculate that these exosomal miRNAs are transferred from the mother's milk to the infant via the digestive tract, and that they play a critical role in the development of the infant immune system.</p> ]]></description>  
<dc:creator>Qi Zhou, Mingzhou Li, Xiaoyan Wang, Qingzhi Li, Tao Wang, Qi Zhu, Xiaochuan Zhou, Xin Wang, Xiaolian Gao, Xuewei Li</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>118</prism:startingPage> 
  <prism:endingPage>123</prism:endingPage> 
  <prism:publicationDate>2011-11-29</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0108.htm</link> 
<title>Identification of Ghrelin Receptor Blocker, D-[Lys3] GHRP-6 as a CXCR4 Receptor Antagonist</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0108.htm</guid> 
<description><![CDATA[ <p>[D-Lys3]-Growth Hormone Releasing Peptide-6 (DLS) is widely utilized <i>in vivo</i> and <i>in vitro</i> as a selective ghrelin receptor (GHS-R) antagonist. Unexpectedly, we identified that DLS also has the ability to block CXCL12 binding and activity through CXCR4 on T cells and peripheral blood mononuclear cells (PBMCs). Moreover, as CXCR4 has been shown to act as a major co-receptor for HIV-1 entry into CD4 positive host cells, we have also found that DLS partially blocks CXCR4-mediated HIV-1 entry and propagation in activated human PBMCs. These data demonstrate that DLS is not the specific and selective antagonist as thought for GHS-R1a and appears to have additional effects on the CXCR4 chemokine receptor. Our findings also suggest that structural analogues that mimic DLS binding properties may also have properties of blocking HIV infectivity, CXCR4 dependent cancer cell migration and attenuating chemokine-mediated immune cell trafficking in inflammatory disorders.</p> ]]></description>  
<dc:creator>Kalpesh Patel, Vishwa Deep Dixit, Jun Ho Lee, Jie Wan Kim, Eric M. Schaffer, Dzung Nguyen, Dennis D. Taub</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>108</prism:startingPage> 
  <prism:endingPage>117</prism:endingPage> 
  <prism:publicationDate>2011-11-26</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0093.htm</link> 
<title>The Complete Mitochondrial Genome of the Damsel Bug Alloeorhynchus bakeri (Hemiptera: Nabidae)</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0093.htm</guid> 
<description><![CDATA[ <p>The complete sequence of the mitochondrial DNA (mtDNA) of the damsel bug, <i>Alloeorhynchus bakeri</i>, has been completed and annotated in this study. It represents the first sequenced mitochondrial genome of heteropteran family Nabidae. The circular genome is 15, 851 bp in length with an A+T content of 73.5%, contains the typical 37 genes that are arranged in the same order as that of the putative ancestor of hexapods. Nucleotide composition and codon usage are similar to other known heteropteran mitochondrial genomes. All protein-coding genes (PCGs) use standard initiation codons (methionine and isoleucine), except<i> COI</i>, which started with TTG. Canonical TAA and TAG termination codons are found in eight protein-coding genes, the remaining five (<i>COI</i>, <i>COII</i>, <i>COIII</i>, <i>ND5</i>, <i>ND1</i>) have incomplete termination codons (T or TA). PCGs of two strands present opposite CG skew which is also reflected by the nucleotide composition and codon usage. All tRNAs have the typical clover-leaf structure, except the dihydrouridine (DHU) arm of<i> tRNA<sup>Ser (AGN)</sup> </i>which forms a simple loop as known in many other metazoa. Secondary structure models of the ribosomal RNA genes of <i>A. bakeri</i> are presented, similar to those proposed for other insect orders. There are six domains and 45 helices and three domains and 27 helices in the secondary structures of<i> rrnL</i> and <i>rrnS</i>, respectively. The major non-coding region (also called control region) between the small ribosomal subunit and the <i>tRNA<sup>Ile </sup></i>gene includes two special regions. The first region includes four 133 bp tandem repeat units plus a partial copy of the repeat (28 bp of the beginning), and the second region at the end of control region contains 4 potential stem-loop structures. Finally, PCGs sequences were used to perform a phylogenetic study. Both maximum likelihood and Bayesian inference analyses highly support Nabidae as the sister group to Anthocoridae and Miridae.</p> ]]></description>  
<dc:creator>Hu Li, Haiyu Liu, Liangming Cao, Aimin Shi, Hailin Yang, Wanzhi Cai</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>93</prism:startingPage> 
  <prism:endingPage>107</prism:endingPage> 
  <prism:publicationDate>2011-11-24</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0079.htm</link> 
<title>The Putative Metal Coordination Motif in the Endonuclease Domain of Human Parvovirus B19 NS1 Is Critical for NS1 Induced S Phase Arrest and DNA Damage</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0079.htm</guid> 
<description><![CDATA[ <p>The non-structural proteins (NS) of the parvovirus family are highly conserved multi-functional molecules that have been extensively characterized and shown to be integral to viral replication. Along with NTP-dependent helicase activity, these proteins carry within their sequences domains that allow them to bind DNA and act as nucleases in order to resolve the concatameric intermediates developed during viral replication. The parvovirus B19 NS1 protein contains sequence domains highly similar to those previously implicated in the above-described functions of NS proteins from adeno-associated virus (AAV), minute virus of mice (MVM) and other non-human parvoviruses. Previous studies have shown that transient transfection of B19 NS1 into human liver carcinoma (HepG2) cells initiates the intrinsic apoptotic cascade, ultimately resulting in cell death. In an effort to elucidate the mechanism of mammalian cell demise in the presence of B19 NS1, we undertook a mutagenesis analysis of the protein's endonuclease domain. Our studies have shown that, unlike wild-type NS1, which induces an accumulation of DNA damage, S phase arrest and apoptosis in HepG2 cells, disruptions in the metal coordination motif of the B19 NS1 protein reduce its ability to induce DNA damage and to trigger S phase arrest and subsequent apoptosis. These studies support our hypothesis that, in the absence of replicating B19 genomes, NS1-induced host cell DNA damage is responsible for apoptotic cell death observed in parvoviral infection of non-permissive mammalian cells.</p> ]]></description>  
<dc:creator>Violetta Kivovich, Leona Gilbert, Matti Vuento, Stanley J. Naides</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>79</prism:startingPage> 
  <prism:endingPage>92</prism:endingPage> 
  <prism:publicationDate>2011-11-24</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0066.htm</link> 
<title>Proteomic Analysis on Acetate Metabolism in Citrobacter sp. BL-4</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0066.htm</guid> 
<description><![CDATA[ <p>Mass production of glucosamine (GlcN) using microbial cells is a worthy approach to increase added values and keep safety problems in GlcN production process. Prior to set up a microbial cellular platform, this study was to assess acetate metabolism in <i>Citrobacter</i> sp. BL-4 (BL-4) which has produced a polyglucosamine PGB-2. The LC-MS analysis was conducted after protein separation on the 1D-PAGE to accomplish the purpose of this study. 280 proteins were totally identified and 188 proteins were separated as acetate-related proteins in BL-4. Acetate was converted to acetyl-CoA by acetyl-CoA synthetase up-regulated in the acetate medium. The glyoxylate bypass in the acetate medium was up-regulated with over-expression of isocitrate lyases and 2D-PAGE confirmed this differential expression. Using <sup>1</sup>H-NMR analysis, the product of isocitrate lyases, succinate, increased about 15 times in the acetate medium. During acetate metabolism proteins involved in the lipid metabolism and hexosamine biosynthesis were over-expressed in the acetate medium, while proteins involved in TCA cycle, pentose phosphate cycle and purine metabolism were down-regulated. Taken together, the results from the proteomic analysis can be applied to improve GlcN production and to develop metabolic engineering in BL-4.</p> ]]></description>  
<dc:creator>Young-Man Kim, Sung-Eun Lee, Byeoung-Soo Park, Mi-Kyung Son, Young-Mi Jung, Seung-Ok Yang, Hyung-Kyoon Choi, Sung-Ho Hur, Jong Hwa Yum</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>66</prism:startingPage> 
  <prism:endingPage>78</prism:endingPage> 
  <prism:publicationDate>2011-11-23</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0059.htm</link> 
<title>EZH2 Methyltransferase and H3K27 Methylation in Breast Cancer</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0059.htm</guid> 
<description><![CDATA[ <p>Histone modifications are thought to control the regulation of genetic programs in normal physiology and cancer. Methylation (mono-, di-, and tri-methylation) on histone H3 lysine (K) 27 induces transcriptional repression, and thereby participates in controlling gene expression patterns. Enhancer of zeste (EZH) 2, a methyltransferase and component of the polycomb repressive complex 2 (PRC2), plays an essential role in the epigenetic maintenance of the H3K27me3 repressive chromatin mark. Abnormal EZH2 expression has been associated with various cancers including breast cancer. Here, we discuss the contribution of EZH2 and the PRC2 complex in controlling the H3K27 methylation status and subsequent consequences on genomic instability and the cell cycle in breast cancer cells. We also discuss distinct molecular mechanisms used by EZH2 to suppress BRCA1 functions.</p> ]]></description>  
<dc:creator>Kyung Hyun Yoo, Lothar Hennighausen</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>59</prism:startingPage> 
  <prism:endingPage>65</prism:endingPage> 
  <prism:publicationDate>2011-11-18</prism:publicationDate> 
<prism:section>Review</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0049.htm</link> 
<title>Localization, Expression Change in PRRSV Infection and Association Analysis of the Porcine TAP1 Gene</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0049.htm</guid> 
<description><![CDATA[ <p>The transporter associated with antigen processing (TAP) translocates antigenic peptides from the cytosol into the lumen of the endoplasmic reticular and plays a critical role in the major histocompatibility complex (MHC) class I molecule-mediated antigenic presentation pathway. In this study, the porcine <i>TAP1</i> gene was mapped to the pig chromosome 7 (SSC7) and was closely linked to the marker SSC2B02 (retention fraction=43%, LOD=15.18). Subcellular localization of TAP1 by transient transfection of PK15 cells indicated that the TAP1 protein might be located in the endoplasmic reticulum (ER) in pig kidney epithelial cells (PK-15). Gene expression analysis by semi-quantitative RT-PCR revealed that <i>TAP1</i> was selectively expressed in some immune and immune-related tissues. Quantitative real-time PCR (qRT-PCR) analysis revealed that this gene was up-regulated after treatments that mimic viral and bacterial infection (polyriboinosinic-polyribocytidylic acid (poly(I:C)) and lipopolysaccharide (LPS), respectively). In addition, elevated <i>TAP1</i> expression was detected after porcine reproductive and respiratory syndrome virus (PRRSV) infection in porcine white blood cells (WBCs). One single nucleotide polymorphism (SNP) in exon 3 of <i>TAP1</i> was detected in a Landrace pig population by <i>Bsp143</i>I restriction enzyme digestion. Different genotypes of this SNP had significant associations (<i>P</i>&#60;0.05) with the red blood cell distribution width (RDW) of 1-day-old (1 d) pigs (<i>P</i>=0.0168), the PRRSV antibody level (PRRSV Ab) (<i>P</i>=0.0445) and the absolute lymphocyte count (LYM#) (<i>P</i>=0.024) of 17 d pigs. Our results showed that the <i>TAP1</i> gene might have important roles in swine immune responses, and these results provide useful information for further functional studies.</p> ]]></description>  
<dc:creator>Nunu Sun, Dewu Liu, Hongbo Chen, Xiangdong Liu, Fanming Meng, Xianwei Zhang, Huiyong Chen, Shengsong Xie, Xinyun Li, Zhenfang Wu</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>49</prism:startingPage> 
  <prism:endingPage>58</prism:endingPage> 
  <prism:publicationDate>2011-11-17</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0039.htm</link> 
<title>Two Closely Related Human Members of Chitinase-like Family, CHI3L1 and CHI3L2, Activate ERK1/2 in 293 and U373 Cells but Have the Different Influence on Cell Proliferation</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0039.htm</guid> 
<description><![CDATA[ <p>The activation of extracellular signal-regulated kinases (ERK1/2) has been associated with specific outcomes. Sustained activation of ERK1/2 by nerve growth factor (NGF) is associated with translocation of ERKs to the nucleus of PC12 cells and precedes their differentiation into sympathetic-like neurons whereas transient activation by epidermal growth factor (EGF) leads to cell proliferation. It was demonstrated that different growth factors initiating the same cellular signaling pathways may lead to the different cell destiny, either to proliferation or to the inhibition of mitogenesis and apoptosis. Thus, further investigation on kinetic differences in activation of certain signal cascades in different cell types by biologically different agents are necessary for understanding the mechanisms as to how cells make a choice between proliferation and differentiation.</p><p>It was reported that chitinase 3-like 1 (CHI3L1) protein promotes the growth of human synovial cells as well as skin and fetal lung fibroblasts similarly to insulin-like growth factor 1 (IGF1). Both are involved in mediating the mitogenic response through the signal-regulated kinases ERK1/2. In addition, CHI3L1 which is highly expressed in different tumors including glioblastomas possesses oncogenic properties. As we found earlier, chitinase 3-like 2 (CHI3L2) most closely related to human CHI3L1 also showed increased expression in glial tumors at both the RNA and protein levels and stimulated the activation of the MAPK pathway through phosphorylation of ERK1/2 in 293 and U87 MG cells. The work described here demonstrates the influence of CHI3L2 and CHI3L1 on the duration of MAPK cellular signaling and phosphorylated ERK1/2 translocation to the nucleus. In contrast to the activation of ERK1/2 phosphorylation by CHI3L1 that leads to a proliferative signal (similar to the EGF effect in PC12 cells), activation of ERK1/2 phosphorylation by CHI3L2 (similar to NGF) inhibits cell mitogenesis and proliferation.</p> ]]></description>  
<dc:creator>Pavlo O. Areshkov, Stanislav S. Avdieiev, Olena V. Balynska, Derek LeRoith, Vadym M. Kavsan</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>39</prism:startingPage> 
  <prism:endingPage>48</prism:endingPage> 
  <prism:publicationDate>2011-11-16</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0030.htm</link> 
<title>Serum Bone Alkaline Phosphatase in Assessing Illness Severity of Infected Neonates in the Neonatal Intensive Care Unit</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0030.htm</guid> 
<description><![CDATA[ <p><b>Background</b>: Infections can influence bone metabolism of neonates, which may lead to changes in some bone metabolism biomarkers. The purpose of this study was to determine whether serum bone alkaline phosphatase (BALP), osteocalcin (OC) and beta carboxy-terminal peptide of type I collagen (CTX), as specific biomarkers of bone metabolism, can be used to assess the severity of neonatal infections.</p><p><b>Methods</b>: Sixty-three neonates in the NICU were enrolled in this study. The neonates were divided into infected group (n=33) and non-infected group (n=30). The scores for neonatal acute physiology-perinatal extension II (SNAPPE-II) were calculated and interleukin-6 (IL-6), procalcitonin (PCT), BALP, OC and CTX were measured among the neonates with or without infections, and among the infected neonates before and after treatment.</p><p><b>Results</b>: The serum BALP levels were lower in the infected group than that in the non-infected group (<i>p</i>&#60;0.01). The serum BALP levels increased markedly in the infected neonates after treatment (<i>p</i>&#60;0.01). The serum BALP levels were also inversely correlated with SNAPPE-II of infected neonates before and after treatment (r=-0.56, <i>p</i>&#60;0.05; r=-0.37, <i>p</i>&#60;0.05, respectively). In infected neonates, the differences between serum BALP levels before and after treatment were inversely correlated with those of IL-6 levels (<i>p</i>&#60;0.05). There were no significant changes in the OC, CTX and PCT levels in the infected or non-infected group before and after treatment.</p><p><b>Conclusion</b>: Our data suggest that serum BALP level might be used as a marker for assessing the severity of illness in infected neonates.</p> ]]></description>  
<dc:creator>Yaozong Zhang, Chenguang Xue, Tian Zhu, Xiaolan Du, Nan Su, Huabing Qi, Jing Yang, Yuan Shi, Lin Chen</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>30</prism:startingPage> 
  <prism:endingPage>38</prism:endingPage> 
  <prism:publicationDate>2011-11-9</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0015.htm</link> 
<title>Influence of Five Potential Anticancer Drugs on Wnt Pathway and Cell Survival in Human Biliary Tract Cancer Cells</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0015.htm</guid> 
<description><![CDATA[ <p>Background: The role of Wnt signalling in carcinogenesis suggests compounds targeting this pathway as potential anti-cancer drugs. Several studies report activation of Wnt signalling in biliary tract cancer (BTC) thus rendering Wnt inhibitory drugs as potential candidates for targeted therapy of this highly chemoresistant disease.</p><p>Methods: In this study we analysed five compounds with suggested inhibitory effects on Wnt signalling (DMAT, FH535, myricetin, quercetin, and TBB) for their cytotoxic efficiency, mode of cell death, time- and cell line-dependent characteristics as well as their effects on Wnt pathway activity in nine different BTC cell lines.</p><p>Results: Exposure of cancer cells to different concentrations of the compounds results in a clear dose-dependent reduction of viability for all drugs in the order FH535 &#62; DMAT &#62; TBB &#62; myricetin &#62; quercetin. The first three substances show high cytotoxicity in all tested cell lines, cause a direct cytotoxic effect by induction of apoptosis and inhibit pathway-specific signal transduction in a Wnt transcription factor reporter activity assay. Selected target genes such as growth-promoting cyclin D1 and the cell cycle progression inhibitor p27 are down- and up-regulated after treatment, respectively.</p><p>Conclusions: Taken together, these data demonstrate that the small molecular weight inhibitors DMAT, F535 and TBB have a considerable cytotoxic and possibly Wnt-specific effect on BTC cell lines in vitro. Further in vivo investigation of these drugs as well as of new Wnt inhibitors may provide a promising approach for targeted therapy of this difficult-to-treat tumour.</p> ]]></description>  
<dc:creator>Julia WACHTER, Daniel NEUREITER, Beate ALINGER, Martin PICHLER, Julia FUEREDER, Christian OBERDANNER, Pietro Di FAZIO, Matthias OCKER, Frieder BERR, Tobias KIESSLICH</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>15</prism:startingPage> 
  <prism:endingPage>29</prism:endingPage> 
  <prism:publicationDate>2011-11-7</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<item>
<link>http://www.biolsci.org/v08p0001.htm</link> 
<title>Enhanced Antitumor Efficacy of Gemcitabine by Evodiamine on Pancreatic Cancer via Regulating PI3K/Akt Pathway</title> 
<guid isPermaLink="true">http://www.biolsci.org/v08p0001.htm</guid> 
<description><![CDATA[ <p>Evodiamine has therapeutic potential against cancers. This study was designed to investigate whether combination therapy with gemcitabine and evodiamine enhanced antitumor efficacy in pancreatic cancer.<i> In vitro</i> application of the combination therapy triggered significantly higher frequency of pancreatic cancer cells apoptosis, inhibited the activities of PI3K, Akt, PKA, mTOR and PTEN, and decreased the activation of NF-&#954;B and expression of NF-&#954;B-regulated products.<i> In vivo</i> application of the combination therapy induced significant enhancement of tumor cell apoptosis, reductions in tumor volume, and inhibited activation of mTOR and PTEN. In conclusion, evodiamine can augment the therapeutic effect of gemcitabine in pancreatic cancer through direct or indirect negative regulation of the PI3K/Akt pathway.</p> ]]></description>  
<dc:creator>Wei-Tian Wei, Hui Chen, Zhao-Hong Wang, Zhong-Lin Ni, Hai-Bin Liu, Hong-Fei Tong, Hong-Chun Guo, Dian-Lei Liu, Sheng-Zhang Lin</dc:creator>
<dc:publisher>Ivyspring International Publisher</dc:publisher> 
  <prism:volume>8</prism:volume> 
  <prism:number>1</prism:number> 
  <prism:startingPage>1</prism:startingPage> 
  <prism:endingPage>14</prism:endingPage> 
  <prism:publicationDate>2011-11-5</prism:publicationDate> 
<prism:section>Research Paper</prism:section>
</item>

<atom:link href="http://www.biolsci.org/rss/v8.xml" rel="self" type="application/rss+xml" />
</channel>
</rss>

